{
  "case_id": "Case_13",
  "case_title": "Case_13 - Medical Analysis",
  "case_content": "Complex Urology Case Presentation\n\nPatient Demographics\nAge: 24 years old\nSex: Male\nEthnicity: Middle Eastern (Iranian heritage)\nOccupation: Graduate student in chemistry\n\nChief Complaint\n\"Burning when I urinate and blood in my urine for the past 6 months, on and off\"\n\nHistory of Present Illness\n24-year-old male presents with a 6-month history of intermittent dysuria, gross hematuria, and suprapubic discomfort. Episodes occur every 2-3 weeks, last 3-5 days, then resolve completely. Patient reports no fever during episodes. Pain is described as \"deep burning\" both during and after urination. Has had 4 courses of antibiotics from urgent care with temporary improvement each time.\n\nRecently developed new symptoms: bilateral flank pain, decreased urine output, and weight gain of 8 lbs over 2 weeks. Denies recent travel, new sexual partners, or illicit drug use. Reports family history of \"kidney problems\" in paternal uncle.\n\nPast Medical History\n- Recurrent \"kidney stones\" as teenager (no documentation available)\n- Treated for depression with sertraline 50mg daily for 2 years\n- No known allergies\n\nSocial History\n- PhD student in organic chemistry, works with various solvents and compounds\n- Denies tobacco use\n- Social alcohol use (2-3 drinks/week)\n- Sexually active with one female partner for 8 months\n- Recent immigrant (3 years ago), limited family medical records\n\nPhysical Examination\n- Vital Signs: BP 145/92, HR 88, Temp 37.1\u00b0C, RR 16\n- General: Mild periorbital edema, appears fatigued\n- Genitourinary: No penile discharge, testes normal, mild suprapubic tenderness\n- Costovertebral angle: Bilateral tenderness\n- Extremities: 1+ pitting edema to mid-shins\n\nLaboratory Results\n\nUrinalysis (during symptomatic episode)\n- Color: Dark amber with visible blood\n- Protein: 3+ (300 mg/dL)\n- Blood: 3+\n- RBC: >50/hpf, many dysmorphic\n- WBC: 15-20/hpf\n- Nitrites: Negative\n- Leukocyte esterase: 2+\n- Casts: 3-5 RBC casts/lpf, 1-2 granular casts/lpf\n\nUrine Culture\n- Day 1: Mixed flora <10,000 CFU/mL\n- Day 3: No growth\n\nSerum Chemistry\n- Creatinine: 2.1 mg/dL (baseline unknown)\n- BUN: 45 mg/dL\n- eGFR: 42 mL/min/1.73m\u00b2\n- Sodium: 138 mEq/L\n- Potassium: 4.8 mEq/L\n- Chloride: 104 mEq/L\n\nAdditional Labs\n- CBC: WBC 8,200, Hgb 11.2 g/dL, Plt 180,000\n- ESR: 45 mm/hr\n- CRP: 12 mg/L\n- C3: 45 mg/dL (Low, normal 90-180)\n- C4: 8 mg/dL (Low, normal 10-40)\n- ANA: Positive, 1:160 homogeneous pattern\n- Anti-dsDNA: Pending\n- ANCA: Pending\n\nImaging\n- Renal Ultrasound: Bilateral increased echogenicity, no hydronephrosis, no obvious stones\n- CT Abdomen/Pelvis (non-contrast): Bilateral renal enlargement, no stones identified",
  "model_responses": [
    {
      "model_name": "google/gemma-3-27b-it/free",
      "response": ":\n```json\n{\n    \"primary_diagnosis\": {\n        \"name\": \"Lupus Nephritis\",\n        \"confidence\": 0.85,\n        \"icd_code\": \"N03.2\",\n        \"reasoning\": \"The constellation of symptoms \u2013 intermittent hematuria, dysuria, flank pain, proteinuria (3+), RBC casts, decreased urine output, elevated creatinine (eGFR 42), low C3/C4 complement levels, positive ANA with a homogeneous pattern, and fatigue \u2013 strongly suggests a systemic autoimmune process affecting the kidneys. The patient's age, recent immigrant status (potentially exposing to different environmental triggers), and family history of kidney problems support this. Recurrent 'kidney stones' in the past could have been early manifestations of lupus nephritis. While the urine cultures were negative, this is common in lupus nephritis as it's not typically a bacterial infection.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"IgA Nephropathy\",\n            \"confidence\": 0.7,\n            \"icd_code\": \"N03.0\",\n            \"reasoning\": \"IgA nephropathy can present with recurrent hematuria, flank pain, and proteinuria. However, the low C3/C4 levels and positive ANA make this less likely than lupus nephritis.  The dysmorphic RBCs are consistent with glomerular disease, seen in both conditions.\"\n        },\n        {\n            \"name\": \"Post-infectious Glomerulonephritis\",\n            \"confidence\": 0.5,\n            \"icd_code\": \"N03.9\",\n            \"reasoning\": \"Can present with hematuria, proteinuria, and decreased renal function. However, the chronic, intermittent nature of the symptoms (6 months) and lack of recent reported infection make this less probable. The low complement levels are also less typical of post-infectious glomerulonephritis.\"\n        },\n        {\n            \"name\": \"Interstitial Nephritis (Drug-Induced)\",\n            \"confidence\": 0.4,\n            \"icd_code\": \"N03.1\",\n            \"reasoning\": \"Given the patient's occupation as a chemistry graduate student and exposure to solvents, drug-induced interstitial nephritis is a possibility. However, the systemic symptoms (edema, fatigue) and positive ANA are less consistent with this diagnosis.\"\n        }\n    ],\n    \"key_findings\": [\"Proteinuria 3+\", \"RBC casts\", \"Decreased eGFR (42 mL/min/1.73m\u00b2)\", \"Low C3/C4\", \"Positive ANA\", \"Dysmorphic RBCs\"],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Anti-dsDNA antibody\",\n            \"purpose\": \"To further evaluate for systemic lupus erythematosus (SLE).\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Anti-Smith antibody\",\n            \"purpose\": \"To further evaluate for SLE.\",\n            \"priority\": \"routine\"\n        },\n        {\n            \"test\": \"ANCA panel\",\n            \"purpose\": \"Rule out ANCA-associated vasculitis.\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"24-hour urine protein collection\",\n            \"purpose\": \"Quantify proteinuria.\",\n            \"priority\": \"routine\"\n        },\n        {\n            \"test\": \"Renal biopsy\",\n            \"purpose\": \"Definitive diagnosis and assessment of disease severity.\",\n            \"priority\": \"urgent\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\"Initiate renal protective measures\", \"Fluid management to address edema\"],\n        \"medications\": [\n            {\n                \"drug\": \"ACE inhibitor or ARB\",\n                \"dose\": \"Titrated to tolerance\",\n                \"route\": \"Oral\",\n                \"duration\": \"Ongoing\",\n                \"rationing\": \"Reduce proteinuria and slow disease progression\"\n            },\n            {\n                \"drug\": \"Prednisone\",\n                \"dose\": \"Initiate at 0.5-1mg/kg/day, taper based on response\",\n                \"route\": \"Oral\",\n                \"duration\": \"Variable, dependent on disease activity\",\n                \"rationing\": \"Immunosuppression to control inflammation\"\n            }\n        ],\n        \"monitoring\": [\"Creatinine\", \"eGFR\", \"Urine protein\", \"Blood pressure\", \"C3/C4 levels\", \"Complete blood count\"],\n        \"consultations\": [\n            {\n                \"specialty\": \"Nephrology\",\n                \"urgency\": \"immediate\",\n                \"reason\": \"Evaluation and management of suspected lupus nephritis, biopsy coordination.\"\n            },\n            {\n                \"specialty\": \"Rheumatology\",\n                \"urgency\": \"routine\",\n                \"reason\": \"Confirmation of SLE diagnosis and long-term management.\"\n            }\n        ]\n    },\n    \"red_flags\": [\"Rapidly declining renal function\", \"Nephrotic range proteinuria\", \"Severe hypertension\", \"Signs of active systemic lupus (e.g., rash, arthritis)\"],\n    \"patient_education\": [\"Importance of medication adherence\", \"Signs and symptoms of disease flare-ups\", \"Need for regular follow-up appointments\"],\n    \"follow_up\": {\n        \"timing\": \"Within 1 week with Nephrology and Rheumatology\",\n        \"conditions\": \"Worsening renal function, development of new symptoms, non-compliance with medications\"\n    },\n    \"confidence\": 0.8,\n    \"uncertainties\": [\"The exact etiology of the recurrent 'kidney stones' in the past is unknown due to lack of documentation.\", \"The extent of systemic involvement of lupus, if confirmed, needs further evaluation.\"]\n}\n```",
      "response_time": 1.0,
      "cached": true,
      "case_id": "Case_13",
      "timestamp": "2025-08-11T21:59:35.285153",
      "tokens_used": 2589,
      "input_tokens": 0,
      "output_tokens": 0
    },
    {
      "model_name": "mistralai/mistral-7b-instruct",
      "response": " {\n    \"primary_diagnosis\": {\n        \"name\": \"Most likely: IgA Nephropathy (Berger's Disease)\",\n        \"confidence\": 0.8,\n        \"icd_code\": \"B80.1\",\n        \"reasoning\": \"Chronic hematuria, proteinuria, and renal dysfunction with the presence of RBC casts in urinalysis, positive ANA with homogeneous pattern, and elevated CRP and ESR\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Alternative 1: Renal Cell Carcinoma\",\n            \"confidence\": 0.2,\n            \"icd_code\": \"C64.9\",\n            \"reasoning\": \"Bilateral flank pain, renal enlargement on CT, and positive family history of kidney problems\"\n        },\n        {\n            \"name\": \"Alternative 2: Chronic Pyelonephritis\",\n            \"confidence\": 0.1,\n            \"icd_code\": \"N10.9\",\n            \"reasoning\": \"Recurrent symptoms of dysuria, hematuria, and suprapubic discomfort, with mixed bacterial growth in urine culture (albeit low count)\"\n        },\n        {\n            \"name\": \"Alternative 3: Medication-induced Nephropathy (Sertraline)\",\n            \"confidence\": 0.1,\n            \"icd_code\": \"T40.40\",\n            \"reasoning\": \"Use of sertraline, a medication known to cause nephropathy in some cases\"\n    }],\n    \"key_findings\": [\n        \"Chronic hematuria, proteinuria, and renal dysfunction\",\n        \"Bilateral flank pain, decreased urine output, and weight gain\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Renal biopsy\",\n            \"purpose\": \"To confirm the diagnosis of IgA Nephropathy\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Anti-dsDNA\",\n            \"purpose\": \"To support or rule out systemic lupus erythematosus\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Urine protein electrophoresis\",\n            \"purpose\": \"To evaluate for possible multiple myeloma\",\n            \"priority\": \"routine\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Hospital admission for further evaluation and management\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Antihypertensives\",\n                \"dose\": \"As prescribed by nephrologist\",\n                \"route\": \"PO\",\n                \"duration\": \"Indefinite\",\n                \"rationale\": \"For blood pressure control\"\n            },\n            {\n                \"drug\": \"ACE inhibitor or ARB\",\n                \"dose\": \"As prescribed by nephrologist\",\n                \"route\": \"PO\",\n                \"duration\": \"Indefinite\",\n                \"rationale\": \"For renal protection and management of proteinuria\"\n            }\n        ],\n        \"monitoring\": [\n            \"Blood pressure, creatinine, eGFR, and urine protein-creatinine ratio\",\n            \"Frequency: Daily in hospital, then weekly as an outpatient\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Nephrology\",\n                \"urgency\": \"immediate\",\n                \"reason\": \"To manage kidney disease and determine the need for renal biopsy\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Persistent or worsening renal function\",\n        \"New onset of hypertension or seizures\"\n    ],\n    \"patient_education\": [\n        \"Avoid exposure to potential nephrotoxic substances (e.g., certain medications, solvents)\",\n        \"Maintain a healthy diet and exercise routine to support kidney health\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"1 week after discharge, then as directed by nephrologist\",\n        \"conditions\": \"Return immediately if new onset of gross hematuria, worsening symptoms, or signs of infection\"\n    },\n    \"confidence_in_assessment\": 0.8,\n    \"uncertainties\": [\n        \"Possible contribution of medication (sertraline) to the kidney disease\",\n        \"Possible alternative diagnoses with lower confidence levels\"\n    ]\n}",
      "response_time": 25.012063026428223,
      "cached": true,
      "case_id": "Case_13",
      "timestamp": "2025-08-11T21:27:03.519140",
      "tokens_used": 2963,
      "input_tokens": 1818,
      "output_tokens": 1145
    },
    {
      "model_name": "anthropic/claude-sonnet-4",
      "response": "{\n    \"primary_diagnosis\": {\n        \"name\": \"Systemic Lupus Erythematosus with Lupus Nephritis\",\n        \"confidence\": 0.85,\n        \"icd_code\": \"M32.14\",\n        \"reasoning\": \"Young male with episodic hematuria, proteinuria, dysmorphic RBCs, RBC casts, hypocomplementemia (low C3/C4), positive ANA with homogeneous pattern, acute kidney injury, hypertension, and edema. The episodic nature with complete resolution between episodes is characteristic of lupus flares. Iranian heritage increases risk for SLE.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"IgA Nephropathy\",\n            \"confidence\": 0.7,\n            \"icd_code\": \"N02.8\",\n            \"reasoning\": \"Episodic gross hematuria in young male, especially with possible preceding infections. However, the systemic features, hypocomplementemia, and positive ANA make lupus more likely.\"\n        },\n        {\n            \"name\": \"Post-infectious Glomerulonephritis\",\n            \"confidence\": 0.4,\n            \"icd_code\": \"N05.9\",\n            \"reasoning\": \"Acute nephritis with hematuria and proteinuria, but the chronic episodic nature and positive autoimmune markers argue against this diagnosis.\"\n        },\n        {\n            \"name\": \"ANCA-associated Vasculitis\",\n            \"confidence\": 0.6,\n            \"icd_code\": \"M31.30\",\n            \"reasoning\": \"Can present with glomerulonephritis and systemic symptoms in young adults. Awaiting ANCA results, but positive ANA and hypocomplementemia favor lupus.\"\n        },\n        {\n            \"name\": \"Chemical-induced Nephritis\",\n            \"confidence\": 0.3,\n            \"icd_code\": \"N14.0\",\n            \"reasoning\": \"Occupational exposure to organic solvents could cause renal injury, but the autoimmune markers and episodic pattern suggest primary glomerular disease.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Episodic gross hematuria with dysmorphic RBCs and RBC casts\",\n        \"Significant proteinuria (3+)\",\n        \"Acute kidney injury with decreased eGFR\",\n        \"Hypocomplementemia (low C3 and C4)\",\n        \"Positive ANA with homogeneous pattern\",\n        \"Hypertension and edema suggesting volume overload\",\n        \"Young male of Middle Eastern descent\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Anti-dsDNA antibodies\",\n            \"purpose\": \"Confirm lupus diagnosis and assess disease activity\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"ANCA panel\",\n            \"purpose\": \"Rule out ANCA-associated vasculitis\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Anti-Smith antibodies\",\n            \"purpose\": \"Specific marker for SLE\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Renal biopsy\",\n            \"purpose\": \"Definitive diagnosis and classification of lupus nephritis\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"24-hour urine protein and creatinine clearance\",\n            \"purpose\": \"Quantify proteinuria and assess renal function\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Echocardiogram\",\n            \"purpose\": \"Assess for cardiac involvement and evaluate hypertension\",\n            \"priority\": \"routine\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Admit for further evaluation and management\",\n            \"Strict intake/output monitoring\",\n            \"Daily weights\",\n            \"Blood pressure monitoring and control\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Lisinopril\",\n                \"dose\": \"5mg\",\n                \"route\": \"oral\",\n                \"duration\": \"ongoing\",\n                \"rationale\": \"ACE inhibitor for hypertension and renoprotection\"\n            },\n            {\n                \"drug\": \"Furosemide\",\n                \"dose\": \"20mg\",\n                \"route\": \"oral\",\n                \"duration\": \"as needed\",\n                \"rationale\": \"Manage fluid overload and edema\"\n            },\n            {\n                \"drug\": \"Prednisone\",\n                \"dose\": \"1mg/kg (hold pending biopsy)\",\n                \"route\": \"oral\",\n                \"duration\": \"variable\",\n                \"rationale\": \"Immunosuppression for suspected lupus nephritis\"\n            }\n        ],\n        \"monitoring\": [\n            \"Daily creatinine and electrolytes\",\n            \"Daily weights and fluid balance\",\n            \"Blood pressure monitoring\",\n            \"Urinalysis every 2-3 days\",\n            \"Complete blood count\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Nephrology\",\n                \"urgency\": \"immediate\",\n                \"reason\": \"Acute kidney injury with suspected glomerulonephritis requiring urgent evaluation and possible biopsy\"\n            },\n            {\n                \"specialty\": \"Rheumatology\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"Suspected systemic lupus erythematosus requiring specialist evaluation and management\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Rapidly declining renal function\",\n        \"Severe hypertension\",\n        \"Pulmonary edema\",\n        \"Oliguria or anuria\",\n        \"Signs of uremia\",\n        \"Neurological symptoms suggesting CNS lupus\"\n    ],\n    \"patient_education\": [\n        \"Explain suspected diagnosis of lupus nephritis and need for urgent evaluation\",\n        \"Importance of medication compliance and follow-up\",\n        \"Monitor for signs of disease flare\",\n        \"Dietary sodium restriction\",\n        \"Avoid nephrotoxic medications and substances\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"Within 48-72 hours after discharge or sooner if admitted\",\n        \"conditions\": \"Return immediately for worsening kidney function, severe hypertension, difficulty breathing, decreased urine output, or neurological symptoms\"\n    },\n    \"confidence_in_assessment\": 0.8,\n    \"uncertainties\": [\n        \"Pending anti-dsDNA and ANCA results may alter diagnosis\",\n        \"Renal biopsy needed for definitive classification\",\n        \"Unclear baseline renal function\",\n        \"Possible occupational exposure contribution unclear\"\n    ]\n}",
      "response_time": 1.0,
      "cached": true,
      "case_id": "Case_13",
      "timestamp": "2025-08-11T22:00:29.425864",
      "tokens_used": 3045,
      "input_tokens": 0,
      "output_tokens": 0
    },
    {
      "model_name": "x-ai/grok-4",
      "response": "{\n  \"primary_diagnosis\": \"Systemic Lupus Erythematosus (SLE) with Lupus Nephritis\",\n  \"differential_diagnoses\": [\n    \"IgA Nephropathy (Berger's Disease)\",\n    \"Membranoproliferative Glomerulonephritis (MPGN)\",\n    \"ANCA-Associated Vasculitis (e.g., Granulomatosis with Polyangiitis)\",\n    \"Post-Infectious Glomerulonephritis\",\n    \"Chemical-Induced Nephrotoxicity (occupational exposure)\",\n    \"Hereditary Nephritis (e.g., Alport Syndrome, given family history)\"\n  ],\n  \"key_findings\": [\n    \"Intermittent dysuria, gross hematuria, and suprapubic pain for 6 months, with recent acute worsening including bilateral flank pain, oliguria, edema, and weight gain\",\n    \"Physical exam: Hypertension (145/92), periorbital and lower extremity edema, bilateral CVA tenderness\",\n    \"Urinalysis: Proteinuria (3+), hematuria with dysmorphic RBCs and RBC casts, pyuria without nitrites (sterile pyuria)\",\n    \"Negative urine culture ruling out active infection\",\n    \"Acute kidney injury: Elevated creatinine (2.1 mg/dL), BUN (45 mg/dL), eGFR (42 mL/min/1.73m\u00b2)\",\n    \"Hypocomplementemia (low C3 and C4), positive ANA (1:160 homogeneous), elevated ESR/CRP, mild anemia\",\n    \"Imaging: Bilateral renal enlargement with increased echogenicity, no stones or hydronephrosis\",\n    \"Occupational exposure to chemicals as chemistry student; family history of kidney problems\"\n  ],\n  \"diagnostic_tests\": [\n    \"Urgent renal biopsy to confirm glomerulonephritis subtype\",\n    \"Complete pending labs: Anti-dsDNA, ANCA (p-ANCA, c-ANCA), anti-GBM antibodies\",\n    \"Additional serologies: ASO titer, anti-streptolysin O, hepatitis B/C serologies, HIV, cryoglobulins\",\n    \"24-hour urine protein quantification and creatinine clearance\",\n    \"Repeat serum creatinine and electrolytes to monitor renal function\",\n    \"Echocardiogram if concern for cardiac involvement in SLE\",\n    \"Consider genetic testing for hereditary nephropathies if biopsy inconclusive\"\n  ],\n  \"management_plan\": {\n    \"immediate\": \"Admit to hospital for monitoring of renal function, blood pressure control (target <130/80 with ACE inhibitor if tolerated, e.g., lisinopril), fluid/electrolyte management, and low-salt diet. Nephrology consult urgently.\",\n    \"pharmacologic\": \"If anti-dsDNA positive confirming SLE, initiate high-dose corticosteroids (e.g., prednisone 1 mg/kg) and immunosuppressive therapy (e.g., mycophenolate mofetil or cyclophosphamide). Hold antibiotics unless infection confirmed.\",\n    \"supportive\": \"Monitor for complications like hyperkalemia or worsening edema; consider diuretics (e.g., furosemide) for volume overload. Discontinue sertraline if drug-induced lupus suspected (rare).\",\n    \"long_term\": \"Multidisciplinary care including rheumatology if SLE confirmed; occupational health evaluation for chemical exposures.\"\n  },\n  \"red_flags\": [\n    \"Rapidly worsening renal function (rising creatinine, oliguria/anuria)\",\n    \"Severe hypertension or hypertensive emergency\",\n    \"Signs of pulmonary edema or heart failure from fluid overload\",\n    \"Development of fever suggesting infection or active vasculitis\",\n    \"Neurologic symptoms (e.g., seizures) if SLE with CNS involvement\"\n  ],\n  \"patient_education\": [\n    \"Explain potential diagnosis of autoimmune kidney disease (e.g., lupus nephritis) causing blood/protein in urine and kidney dysfunction; emphasize need for biopsy to confirm.\",\n    \"Advise on symptoms to watch for: worsening swelling, shortness of breath, decreased urine output, or new rashes/joint pains.\",\n    \"Discuss lifestyle: Limit salt intake, monitor weight daily, avoid NSAIDs, and report any chemical exposures at work.\",\n    \"Stress adherence to medications and follow-up; discuss potential need for long-term immunosuppression and risks (e.g., infection).\"\n  ],\n  \"follow_up\": \"Immediate nephrology follow-up within 24-48 hours if not admitted; rheumatology consult if SLE confirmed. Repeat labs in 1 week or sooner if symptoms worsen. Long-term monitoring every 1-3 months depending on stability.\",\n  \"confidence_in_assessment\": \"Moderate (70%) \u2013 Strong evidence for SLE nephritis but awaiting confirmatory tests like anti-dsDNA and biopsy.\",\n  \"uncertainties\": [\n    \"Baseline renal function unknown (no prior creatinine), so unclear if acute or chronic kidney disease\",\n    \"Exact role of occupational chemical exposure vs. autoimmune process\",\n    \"Family history details limited due to immigration; possible hereditary component\",\n    \"Pending serologies (anti-dsDNA, ANCA) may shift diagnosis toward vasculitis or other GN\"\n  ]\n}",
      "response_time": 1.0,
      "cached": true,
      "case_id": "Case_13",
      "timestamp": "2025-08-11T22:02:39.368618",
      "tokens_used": 0,
      "input_tokens": 0,
      "output_tokens": 0
    },
    {
      "model_name": "openai/gpt-oss-120b",
      "response": "We need to produce JSON only. Provide diagnostic assessment. Likely primary diagnosis: IgA nephropathy (IgA nephropathy causing hematuria, proteinuria, renal dysfunction, low complement? Actually IgA usually normal complement. Low C3/C4 suggests complement-mediated disease like lupus nephritis, or membranoproliferative GN (MPGN) or post-infectious GN (low C3). But ANA positive, low complement both C3 and C4 low, suggests systemic lupus erythematosus (SLE) with lupus nephritis. Age 24 male, but lupus can affect males. RBC casts, proteinuria 3+, renal dysfunction, edema. Could be lupus nephritis (class III/IV). Also could be ANCA-associated vasculitis (e.g., microscopic polyangiitis) but complement usually normal. Low complement suggests immune complex disease: lupus, MPGN, post-infectious (but chronic). Also complement low C4 also low suggests lupus (C4 low). So primary diagnosis: Lupus nephritis (likely class III/IV). Need to consider other differential: IgA nephropathy (Berger disease) (but complement usually normal). Membranous nephropathy (but complement normal). Post-infectious GN (low C3 but C4 normal). ANCA-associated vasculitis (GPA, MPA) (normal complement). Alport? not.\n\nAlso consider renal stone disease? but imaging no stones.\n\nAlso consider drug-induced interstitial nephritis? but RBC casts suggests glomerular.\n\nThus primary: Lupus nephritis.\n\nProvide ICD-10: N08.9 (Nephritic syndrome) but more specific: N05.9? Actually Lupus nephritis is N08.9? Let's check: Lupus nephritis is N05.9? Actually ICD-10: N08.9 is \"Renal tubulo-interstitial disease, unspecified\"? Wait. Let's recall: ICD-10 code for \"Lupus nephritis\" is N05.9 (Systemic lupus erythematosus with renal involvement). Or maybe \"Lupus nephritis\" is N05.9? Actually N05 is \"Systemic lupus erythematosus with organ involvement\". N05.9 is \"Systemic lupus erythematosus with renal involvement, unspecified\". Could use N05.9. Also could use N08.9 for \"Nephritic syndrome, unspecified\". We'll include both.\n\nDifferentials: IgA nephropathy (N02.8), Membranous nephropathy (N04.9), ANCA-associated vasculitis (M31.7 for microscopic polyangiitis?). Also post-infectious glomerulonephritis (N00.9). Also consider acute interstitial nephritis (N10). Provide three.\n\nKey findings: RBC casts, proteinuria, low complement, positive ANA, hypertension, edema.\n\nDiagnostic tests: ANA panel (anti-dsDNA, anti-Smith), complement repeat, anti-dsDNA result, ANCA (pending), anti-GBM antibodies, complement levels, renal biopsy (gold standard), urine protein quantification (24h), complement C3, C4, complement labs, kidney ultrasound (done), CT, but need renal biopsy.\n\nAlso test for hepatitis B/C, HIV.\n\nManagement: immediate nephrology consult, start high-dose steroids (e.g., prednisone 1 mg/kg), consider immunosuppression (e.g., mycophenolate mofetil or cyclophosphamide) after biopsy. Manage hypertension (ACE inhibitor), avoid nephrotoxic agents, monitor labs.\n\nNow produce JSON.\n\nMake sure JSON is valid, no trailing commas, proper quoting.\n\nLet's craft.\n\n\n\n---\n\n{\n    \"primary_diagnosis\": {\n        \"name\": \"Lupus nephritis (likely Class III/IV proliferative lupus nephritis)\",\n        \"confidence\": 0.78,\n        \"icd_code\": \"N05.9\",\n        \"reasoning\": \"Young adult male with persistent hematuria, proteinuria (3+), RBC casts, reduced eGFR, hypertension, edema, low C3 and C4, and positive ANA suggest an immune\u2011complex glomerulonephritis. Low complement levels and ANA positivity point strongly toward systemic lupus erythematosus with renal involvement. The rapid decline in renal function and systemic signs (edema, hypertension) are consistent with proliferative lupus nephritis.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"IgA nephropathy (Berger disease)\",\n            \"confidence\": 0.45,\n            \"icd_code\": \"N02.8\",\n            \"reasoning\": \"IgA nephropathy presents with episodic gross hematuria, proteinuria, and RBC casts in a young adult. However, complement levels are usually normal, which makes it less likely than lupus nephritis.\"\n        },\n        {\n            \"name\": \"ANCA\u2011associated vasculitis (e.g., microscopic polyangiitis)\",\n            \"confidence\": 0.30,\n            \"icd_code\": \"M31.7\",\n            \"reasoning\": \"ANCA vasculitis can cause rapidly progressive glomerulonephritis with hematuria, proteinuria, and systemic hypertension. Complement levels are typically normal; pending ANCA results will help rule this in or out.\"\n        },\n        {\n            \"name\": \"Post\u2011infectious (post\u2011streptococcal) glomerulonephritis\",\n            \"confidence\": 0.25,\n            \"icd_code\": \"N00.9\",\n            \"reasoning\": \"Can cause low C3 with hematuria and proteinuria, but usually follows a recent infection and C4 is normal. The chronic 6\u2011month course and lack of recent infection make this less likely.\"\n        }\n    ],\n    \"key_findings\": [\n        \"RBC casts, dysmorphic RBCs, and 3+ protein on urinalysis\",\n        \"Low complement C3 (45 mg/dL) and C4 (8 mg/dL) with positive ANA (1:160)\",\n        \"Elevated serum creatinine 2.1\u202fmg/dL with eGFR 42\u202fmL/min/1.73\u202fm\u00b2, hypertension, edema\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Renal biopsy with immunofluorescence and electron microscopy\",\n            \"purpose\": \"Definitive classification of lupus nephritis vs other GN; guides immunosuppression\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Anti\u2011dsDNA, anti\u2011Smith (anti\u2011Sm), anti\u2011RNP antibodies\",\n            \"purpose\": \"Confirm SLE activity and correlate with renal disease\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"ANCA (p\u2011ANCA, c\u2011ANCA) with MPO and PR3 specificity\",\n            \"purpose\": \"Rule out ANCA\u2011associated vasculitis\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Complement C3, C4 repeat\",\n            \"purpose\": \"Trend disease activity\",\n            \"priority\": \"routine\"\n        },\n        {\n            \"test\": \"24\u2011hour urine protein quantification\",\n            \"purpose\": \"Quantify proteinuria for staging and treatment decisions\",\n            \"priority\": \"routine\"\n        },\n        {\n            \"test\": \"Hepatitis B & C serology, HIV testing\",\n            \"purpose\": \"Identify secondary causes of immune\u2011complex GN\",\n            \"priority\": \"routine\"\n        },\n        {\n            \"test\": \"Renal Doppler ultrasound\",\n            \"purpose\": \"Assess renal blood flow, rule out vascular obstruction\",\n            \"priority\": \"routine\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Admit to hospital for renal monitoring and work\u2011up\",\n            \"Begin high\u2011dose oral prednisone 1\u202fmg/kg/day (max 80\u202fmg) pending biopsy results\",\n            \"Start ACE inhibitor (e.g., lisinopril 5\u202fmg PO daily) to control hypertension and reduce proteinuria, if not contraindicated\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Prednisone\",\n                \"dose\": \"1\u202fmg/kg/day (max 80\u202fmg) PO daily\",\n                \"route\": \"PO\",\n                \"duration\": \"4\u20116 weeks with taper based on response and biopsy results\",\n                \"rationale\": \"Induction therapy for proliferative lupus nephritis\"\n            },\n            {\n                \"drug\": \"Mycophenolate mofetil\",\n                \"dose\": \"1\u202fg PO twice daily\",\n                \"route\": \"PO\",\n                \"duration\": \"Induction (6\u201112\u202fmonths) then maintenance\",\n                \"rationale\": \"Immunosuppressive agent for lupus nephritis; alternative to cyclophosphamide\"\n            },\n            {\n                \"drug\": \"Lisinopril\",\n                \"dose\": \"5\u202fmg PO daily, titrate to blood pressure goal\",\n                \"route\": \"PO\",\n                \"duration\": \"Long\u2011term\",\n                \"rationale\": \"Renoprotective, reduces proteinuria and controls hypertension\"\n            }\n        ],\n        \"monitoring\": [\n            \"Serum creatinine, eGFR, BUN, electrolytes daily while inpatient\",\n            \"Urine protein/creatinine ratio weekly\",\n            \"Blood pressure daily\",\n            \"Complete blood count weekly (",
      "response_time": 3.8946430683135986,
      "cached": true,
      "case_id": "Case_13",
      "timestamp": "2025-08-11T21:24:48.976572",
      "tokens_used": 3509,
      "input_tokens": 1509,
      "output_tokens": 2000
    },
    {
      "model_name": "cohere/command-r",
      "response": "{\n    \"primary_diagnosis\": {\n        \"name\": \"Acute Pyelonephritis with Renal Parenchymal Disease\",\n        \"confidence\": 0.85,\n        \"icd_code\": \"N10.9\",\n        \"reasoning\": \"Pyelonephritis is a likely cause of the patient's symptoms, given the history of recurrent urinary tract infections, bilateral flank pain, and positive urinalysis with leukocyte esterase and nitrites. The renal ultrasound and CT findings suggest bilateral renal abnormalities.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Interstitial Nephritis\",\n            \"confidence\": 0.1,\n            \"icd_code\": \"N04.9\",\n            \"reasoning\": \"The acute onset of symptoms, bilateral involvement, and pending ANA/anti-dsDNA results make this a consideration. However, the lack of renal failure and normal eGFR do not fully support this diagnosis.\"\n        },\n        {\n            \"name\": \"Renal Tubular Necrosis\",\n            \"confidence\": 0.05,\n            \"icd_code\": \"N17.8\",\n            \"reasoning\": \"The acute kidney injury and increased protein in the urine suggest this diagnosis, but the history and labs do not reveal any clear toxins or medications that could cause tubular necrosis.\"\n        },\n        {\n            \"name\": \"Acute Glomerulonephritis\",\n            \"confidence\": 0.1,\n            \"icd_code\": \"N03.9\",\n            \"reasoning\": \"The low complement levels and positive ANA indicate possible glomerular involvement, but the relatively mild symptoms and lack of significant proteinuria do not fully support acute GN.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Visible hematuria and dysuria\",\n        \"Bilateral flank pain, tender costovertebral angles\",\n        \"Mild edema to mid-shins, elevated BUN and creatinine\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Anti-dsDNA Antibodies\",\n            \"purpose\": \"Help confirm or rule out systemic lupus erythematosus as a cause of the renal symptoms\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"ANCA Screen\",\n            \"purpose\": \"Detect ANCA-associated vasculitis, another potential cause of renal symptoms\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Renal Biopsy\",\n            \"purpose\": \"Obtain definitive diagnosis if other tests are inconclusive\",\n            \"priority\": \"routine\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Initiate IV Fluids for hydration and kidney support\",\n            \"Start IV Antibiotics (e.g., Ceftriaxone) for possible UTI\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Ceftriaxone\",\n                \"dose\": \"1g daily\",\n                \"route\": \"IV\",\n                \"duration\": \"14 days\",\n                \"rationale\": \"Treat suspected bacterial infection\"\n            },\n            {\n                \"drug\": \"Methylprednisolone\",\n                \"dose\": \"40mg daily\",\n                \"route\": \"PO\",\n                \"duration\": \"1 month\",\n                \"rationale\": \"Reduce possible inflammatory renal damage\"\n            }\n        ],\n        \"monitoring\": [\n            \"Daily urine analysis and culture\",\n            \"Serial serum creatinine and potassium levels\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Nephrology\",\n                \"urgency\": \"immediate\",\n                \"reason\": \"Renal involvement and acute kidney injury\"\n            },\n            {\n                \"specialty\": \"Rheumatology\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"Evaluate for underlying autoimmune disorders\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"High blood pressure - monitor for hypertensive emergencies\",\n        \"Acute kidney injury and potential for chronic kidney disease\"\n    ],\n    \"patient_education\": [\n        \"Explain the importance of treating urinary tract infections promptly\",\n        \"Advise on the chronic nature of kidney conditions and the need for ongoing monitoring\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"2-3 days for renal function monitoring, then 2 weeks, and 3 months\",\n        \"conditions\": \"Uncontrolled blood pressure, worsening kidney function\"\n    },\n    \"confidence_in_assessment\": 0.7,\n    \"uncertainties\": [\n        \"Pending rheumatological test results - cannot exclude underlying autoimmune disorder\",\n        \"Renal ultrasound and CT findings suggest possible renal parenchymal disease, but further evaluation is needed\"\n    ]\n}",
      "response_time": 8.158031225204468,
      "cached": true,
      "case_id": "Case_13",
      "timestamp": "2025-08-11T21:32:28.621024",
      "tokens_used": 2530,
      "input_tokens": 1533,
      "output_tokens": 997
    },
    {
      "model_name": "openai/gpt-4-turbo",
      "response": "{\n    \"primary_diagnosis\": {\n        \"name\": \"Glomerulonephritis\",\n        \"confidence\": 0.85,\n        \"icd_code\": \"N05\",\n        \"reasoning\": \"The patient presents with symptoms and lab findings indicative of glomerular disease, including dysmorphic RBCs, RBC casts, proteinuria, and renal function impairment. The presence of low complement levels and positive ANA suggest an autoimmune etiology.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Lupus Nephritis\",\n            \"confidence\": 0.75,\n            \"icd_code\": \"M32.14\",\n            \"reasoning\": \"Positive ANA and low complement levels are suggestive, awaiting anti-dsDNA results which could confirm diagnosis.\"\n        },\n        {\n            \"name\": \"IgA Nephropathy\",\n            \"confidence\": 0.6,\n            \"icd_code\": \"N02.9\",\n            \"reasoning\": \"Possible given the episodic hematuria and proteinuria, but less likely due to the autoimmune markers.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Dysmorphic RBCs and RBC casts in urine\",\n        \"Low complement levels and positive ANA\",\n        \"Renal ultrasound showing increased echogenicity without stones\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Kidney biopsy\",\n            \"purpose\": \"To confirm diagnosis of glomerulonephritis and differentiate between types\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Anti-dsDNA and ANCA\",\n            \"purpose\": \"To evaluate for specific autoimmune disorders such as lupus or vasculitis\",\n            \"priority\": \"urgent\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Admit to hospital for close monitoring and workup\",\n            \"Initiate fluid management and blood pressure control\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Prednisone\",\n                \"dose\": \"1 mg/kg/day\",\n                \"route\": \"oral\",\n                \"duration\": \"until biopsy results\",\n                \"rationale\": \"To reduce inflammation in the kidneys while awaiting definitive diagnosis\"\n            }\n        ],\n        \"monitoring\": [\n            \"Daily urine output and protein\",\n            \"Serum creatinine and electrolytes\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Nephrology\",\n                \"urgency\": \"immediate\",\n                \"reason\": \"Expert management of suspected glomerulonephritis\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Rapid increase in creatinine\",\n        \"Decrease in urine output\"\n    ],\n    \"patient_education\": [\n        \"Importance of adhering to prescribed medications\",\n        \"Signs of worsening kidney function to monitor\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"1 week after hospital discharge\",\n        \"conditions\": \"Earlier if symptoms worsen or new symptoms appear\"\n    },\n    \"confidence_in_assessment\": 0.85,\n    \"uncertainties\": [\n        \"Exact type of glomerulonephritis pending biopsy and specific antibody tests\",\n        \"Baseline kidney function unknown\"\n    ]\n}",
      "response_time": 1.0,
      "cached": true,
      "case_id": "Case_13",
      "timestamp": "2025-08-11T22:01:18.155348",
      "tokens_used": 1932,
      "input_tokens": 0,
      "output_tokens": 0
    },
    {
      "model_name": "deepseek/deepseek-chat",
      "response": "{\n    \"primary_diagnosis\": {\n        \"name\": \"Lupus Nephritis\",\n        \"confidence\": 0.9,\n        \"icd_code\": \"M32.14\",\n        \"reasoning\": \"The patient presents with hematuria, proteinuria, RBC casts, and elevated creatinine, indicative of glomerulonephritis. Low C3 and C4 complement levels, along with a positive ANA, strongly suggest systemic lupus erythematosus (SLE) with renal involvement. The absence of infection and the family history of kidney problems further support this diagnosis.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"IgA Nephropathy\",\n            \"confidence\": 0.7,\n            \"icd_code\": \"N02.8\",\n            \"reasoning\": \"This condition can present with episodic hematuria, proteinuria, and RBC casts. However, the absence of a recent upper respiratory infection and the presence of systemic autoimmune markers make this less likely.\"\n        },\n        {\n            \"name\": \"Acute Interstitial Nephritis\",\n            \"confidence\": 0.6,\n            \"icd_code\": \"N12\",\n            \"reasoning\": \"This could be considered due to the patient's history of antibiotic use and the presence of WBCs in the urine. However, the presence of RBC casts and the systemic autoimmune markers make this less likely.\"\n        },\n        {\n            \"name\": \"Chronic Pyelonephritis\",\n            \"confidence\": 0.5,\n            \"icd_code\": \"N11.9\",\n            \"reasoning\": \"The bilateral flank pain and WBCs in the urine could suggest chronic infection. However, the absence of fever and the presence of RBC casts and autoimmune markers make this less likely.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Hematuria with RBC casts\",\n        \"Proteinuria\",\n        \"Low C3 and C4 complement levels\",\n        \"Positive ANA\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Kidney Biopsy\",\n            \"purpose\": \"Confirm lupus nephritis and determine the class\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Anti-dsDNA Antibodies\",\n            \"purpose\": \"Further support SLE diagnosis\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"ANCA\",\n            \"purpose\": \"Rule out vasculitis\",\n            \"priority\": \"urgent\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Control blood pressure\",\n            \"Monitor urine output and renal function\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Prednisone\",\n                \"dose\": \"1 mg/kg/day\",\n                \"route\": \"PO\",\n                \"duration\": \"4-6 weeks\",\n                \"rationale\": \"Reduce inflammation and immune response\"\n            },\n            {\n                \"drug\": \"Mycophenolate Mofetil\",\n                \"dose\": \"500 mg twice daily\",\n                \"route\": \"PO\",\n                \"duration\": \"Long-term\",\n                \"rationale\": \"Immunosuppressive therapy for lupus nephritis\"\n            }\n        ],\n        \"monitoring\": [\n            \"Serum creatinine and urine protein\",\n            \"Daily\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Nephrology\",\n                \"urgency\": \"immediate\",\n                \"reason\": \"Management of lupus nephritis\"\n            },\n            {\n                \"specialty\": \"Rheumatology\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"Management of systemic lupus erythematosus\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Rapidly worsening renal function\",\n        \"Severe hypertension\"\n    ],\n    \"patient_education\": [\n        \"Importance of medication adherence\",\n        \"Signs of worsening kidney function\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"1 week\",\n        \"conditions\": \"Increased edema, decreased urine output, or severe pain\"\n    },\n    \"confidence_in_assessment\": 0.9,\n    \"uncertainties\": [\n        \"Exact class of lupus nephritis\",\n        \"Potential drug toxicity from immunosuppressive therapy\"\n    ]\n}",
      "response_time": 9.91514801979065,
      "cached": true,
      "case_id": "Case_13",
      "timestamp": "2025-08-11T21:27:13.436638",
      "tokens_used": 2352,
      "input_tokens": 1448,
      "output_tokens": 904
    },
    {
      "model_name": "google/gemini-2.5-pro",
      "response": "**1. Analyzing the Case**\n\nI'm beginning to dissect the medical case. My primary focus is extracting key patient details \u2013 age, ethnicity, and occupation, which are critical for further analysis. Additionally, I've zeroed in on the chief complaint: intermittent dysuria and gross hematuria, which I will interpret and integrate. I will structure this data into a JSON object for a structured format, to aid with future processes.\n\n\n**2. Structuring Data**\n\nI've now successfully constructed the preliminary JSON object. I've included the patient's demographics, chief complaint, and detailed history of present illness (HPI), including recent developments like flank pain and edema. The past medical history (PMH), social history, and physical exam findings, including vital signs, are also integrated. I'm currently working to build in the most crucial component: the lab results.\n\n\n**3. Interpreting Lab Results**\n\nI've made significant progress! I'm focusing on the critical lab findings. The urinalysis reveals proteinuria, hematuria with dysmorphic RBCs and casts, plus pyuria despite a negative culture. Serum chemistry confirms acute kidney injury, with elevated creatinine and low eGFR. Crucially, low C3 and C4 levels, coupled with a positive ANA, strongly suggest an immune-complex mediated glomerulonephritis, potentially lupus nephritis.\n\n\n**4. Finalizing the Diagnosis**\n\nI'm solidifying the diagnosis. The information has been integrated and synthesized. The episodic hematuria and acute kidney injury in a young, Middle Eastern male, coupled with proteinuria, nephritic sediment, positive ANA, and low complement, strongly indicates Lupus Nephritis. The pending anti-dsDNA and ANCA results will confirm. I've included relevant ICD-10 codes and the confidence level.\n\n\n**5. Refining the Differential**\n\nI'm refining the differential diagnoses to bolster diagnostic certainty. While Lupus Nephritis remains the primary suspect, IgA nephropathy is still on the table, but less likely given the positive ANA and the low C3/C4. Membranoproliferative Glomerulonephritis is considered, given its potential for similar presentation and the low complement, which requires biopsy for differentiation.\n\n\n**6. Formulating the Plan**\n\nI've shifted my focus to the next steps, prioritizing key tests and treatments. Immediate actions include ordering a renal biopsy, which is the gold standard, and administering high-dose steroids, given the acute nature of the kidney injury. I must also address hypertension and fluid overload aggressively. Furthermore, I will review the pending anti-dsDNA and ANCA results, and prepare for further investigation to rule out other causes, to clarify and tailor treatment plans.\n\n\n**7. Refining the Data Object**\n\nI've finalized the core elements of the data object.  Now I'm integrating the details from the HPI and the lab results, in addition to the physical examination, into a single, structured object. This will allow for better readability and analysis. The framework is solid, and I will next work on the management plan and the differential.\n\n\n**8. Integrating Treatment**\n\nI'm now focusing on the immediate plan of action. The patient requires admission, and I'll work on structuring the prescription for the medications and monitoring.  I'm drafting orders for nephrology and rheumatology consults, and I will implement the management plan with these specialist doctors. The overall plan will include diagnostic tests to confirm the diagnosis.\n\n\n",
      "response_time": 22.029000282287598,
      "cached": true,
      "case_id": "Case_13",
      "timestamp": "2025-08-11T21:25:50.018362",
      "tokens_used": 3553,
      "input_tokens": 1554,
      "output_tokens": 1999
    },
    {
      "model_name": "deepseek/deepseek-r1",
      "response": "Okay, let's tackle this medical case. The patient is a 24-year-old male with a 6-month history of intermittent dysuria, hematuria, and suprapubic discomfort. Recent symptoms include flank pain, decreased urine output, and weight gain. His labs show elevated creatinine, proteinuria, hematuria with dysmorphic RBCs and RBC casts. Complement levels are low, ANA is positive. Imaging shows bilateral renal enlargement.\n\nFirst, the key findings here point towards a glomerular disease. The presence of dysmorphic RBCs, RBC casts, proteinuria, and low C3/C4 suggests immune complex-mediated glomerulonephritis. The recurrent nature and response to antibiotics (even temporarily) might have been misleading, but the lack of culture growth and absence of infection signs point elsewhere.\n\nThe top differential would be lupus nephritis given the positive ANA, low complements, and nephritic syndrome presentation. But since anti-dsDNA is pending, I can't confirm yet. However, SLE is common in young females, but males can have it too, especially with his Middle Eastern background where SLE prevalence might be higher.\n\nAnother possibility is IgA nephropathy, which can present with recurrent hematuria. However, IgA usually has normal complements. The low C3/C4 makes me think post-infectious GN, but the timeline is 6 months, which is too long for typical post-strep. Maybe a chronic infection? But he has no recent travel or other signs.\n\nANCA-associated vasculitis is another differential, especially with possible RPGN given the elevated creatinine. But ANCA is pending. The renal ultrasound showing increased echogenicity and enlargement fits with acute glomerulonephritis.\n\nGiven the complement levels and ANA, lupus nephritis is the most likely. The ICD-10 for lupus nephritis is M32.14. Differentials include IgA nephropathy (N02.8), ANCA vasculitis (M31.31 for granulomatosis with polyangiitis), and maybe membranoproliferative GN (N05.8).\n\nThe patient's occupation as a chemist working with solvents might expose him to toxins, but there's no direct link here. His family history of kidney problems could be genetic, but SLE can have familial tendencies too.\n\nUrgent tests needed include kidney biopsy to confirm the diagnosis, anti-dsDNA, ANCA, and maybe anti-GBM antibodies. Immediate management would involve steroids, maybe immunosuppressants once confirmed. Monitoring renal function, BP, and edema is crucial. Consulting nephrology and rheumatology immediately makes sense.\n\nUncertainties include the pending serologies and the exact type of glomerulonephritis without biopsy. Also, his previous kidney stones history might complicate, but current presentation is more glomerular.\n\n\n---\n\n```json\n{\n    \"primary_diagnosis\": {\n        \"name\": \"Lupus nephritis (SLE-related glomerulonephritis)\",\n        \"confidence\": 0.85,\n        \"icd_code\": \"M32.14\",\n        \"reasoning\": \"Young male with nephritic syndrome (hematuria, proteinuria, RBC casts), low C3/C4, positive ANA, elevated ESR/CRP, and renal dysfunction. Family history of kidney disease and Middle Eastern ethnicity increase SLE risk. Clinical course inconsistent with infection given negative cultures and antibiotic failure.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"IgA nephropathy\",\n            \"confidence\": 0.4,\n            \"icd_code\": \"N02.8\",\n            \"reasoning\": \"Recurrent gross hematuria and glomerular injury. However, low complement levels and positive ANA make this less likely.\"\n        },\n        {\n            \"name\": \"ANCA-associated vasculitis\",\n            \"confidence\": 0.35,\n            \"icd_code\": \"M31.31\",\n            \"reasoning\": \"Rapid renal function decline and nephritic sediment, but pending ANCA results. Age atypical but possible.\"\n        },\n        {\n            \"name\": \"Membranoproliferative glomerulonephritis\",\n            \"confidence\": 0.3,\n            \"icd_code\": \"N05.8\",\n            \"reasoning\": \"Low complement levels and nephritic features, but typically associated with chronic infections or autoimmune disorders.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Active urinary sediment (dysmorphic RBCs, RBC casts, proteinuria)\",\n        \"Hypocomplementemia (low C3/C4) with positive ANA\",\n        \"Acute kidney injury (Cr 2.1, elevated BUN)\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Kidney biopsy\",\n            \"purpose\": \"Confirm lupus nephritis class/activity\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Anti-dsDNA antibodies\",\n            \"purpose\": \"Confirm SLE-specific autoimmunity\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Anti-GBM antibodies\",\n            \"purpose\": \"Rule out Goodpasture syndrome\",\n            \"priority\": \"urgent\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"BP control (target <130/80)\",\n            \"Salt/protein restriction diet\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Prednisone\",\n                \"dose\": \"1 mg/kg/day (e.g., 60 mg)\",\n                \"route\": \"PO\",\n                \"duration\": \"4-6 weeks with taper\",\n                \"rationale\": \"Induction therapy for immune-mediated GN\"\n            },\n            {\n                \"drug\": \"Hydroxychloroquine\",\n                \"dose\": \"400 mg daily\",\n                \"route\": \"PO\",\n                \"duration\": \"Long-term\",\n                \"rationale\": \"SLE disease-modifying therapy\"\n            }\n        ],\n        \"monitoring\": [\n            \"Daily weights and strict I/O\",\n            \"Serum creatinine q48h\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Nephrology\",\n                \"urgency\": \"immediate\",\n                \"reason\": \"Biopsy coordination and AKI management\"\n            },\n            {\n                \"specialty\": \"Rheumatology\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"SLE confirmation/systemic management\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Rapidly rising creatinine\",\n        \"New-onset hypertension\"\n    ],\n    \"patient_education\": [\n        \"Avoid NSAIDs/nephrotoxic substances given chemical exposure risk\",\n        \"Report edema, frothy urine, or neurologic symptoms immediately\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"Within 72 hours for biopsy results\",\n        \"conditions\": \"Oliguria, seizure, or chest pain\"\n    },\n    \"confidence_in_assessment\": 0.85,\n    \"uncertainties\": [\n        \"Unknown baseline renal function (possible chronic vs acute injury)\",\n        \"Potential occupational solvent exposure impact (unclear association)\"\n    ]\n}\n```",
      "response_time": 16.85216188430786,
      "cached": true,
      "case_id": "Case_13",
      "timestamp": "2025-08-11T21:27:30.289993",
      "tokens_used": 2934,
      "input_tokens": 1450,
      "output_tokens": 1484
    },
    {
      "model_name": "anthropic/claude-3.5-haiku-20241022",
      "response": "{\n    \"primary_diagnosis\": \"IgA Nephropathy with Possible Lupus Nephritis\",\n    \"differential_diagnoses\": [\n        \"Chronic Glomerulonephritis\",\n        \"ANCA-Associated Vasculitis\",\n        \"Systemic Lupus Erythematosus\",\n        \"Hereditary Nephritis\"\n    ],\n    \"key_findings\": [\n        \"Recurrent hematuria\",\n        \"Proteinuria\",\n        \"Reduced kidney function\",\n        \"Positive ANA\",\n        \"Low complement levels\",\n        \"Dysmorphic RBCs\",\n        \"RBC casts\"\n    ],\n    \"diagnostic_tests\": [\n        \"Kidney biopsy (urgent)\",\n        \"Anti-dsDNA confirmation\",\n        \"ANCA panel\",\n        \"Complete autoimmune workup\"\n    ],\n    \"management_plan\": [\n        \"Renal consultation\",\n        \"Potential immunosuppressive therapy\",\n        \"ACE inhibitor or ARB for kidney protection\",\n        \"Monitor kidney function\",\n        \"Strict fluid and sodium management\"\n    ],\n    \"red_flags\": [\n        \"Rapidly declining kidney function\",\n        \"Persistent proteinuria\",\n        \"Low complement levels\",\n        \"Potential autoimmune process\"\n    ],\n    \"patient_education\": [\n        \"Potential chronic kidney disease\",\n        \"Importance of medication adherence\",\n        \"Dietary modifications\",\n        \"Regular monitoring\",\n        \"Potential genetic counseling\"\n    ],\n    \"follow_up\": {\n        \"nephrology\": \"Within 1 week\",\n        \"lab_tests\": \"Biweekly for 3 months\",\n        \"imaging\": \"Renal ultrasound in 3 months\"\n    },\n    \"confidence_in_assessment\": 0.85,\n    \"uncertainties\": [\n        \"Exact underlying autoimmune mechanism\",\n        \"Potential genetic predisposition\",\n        \"Long-term kidney function prognosis\"\n    ]\n}",
      "response_time": 1.0,
      "cached": true,
      "case_id": "Case_13",
      "timestamp": "2025-08-11T22:02:03.303222",
      "tokens_used": 0,
      "input_tokens": 0,
      "output_tokens": 0
    },
    {
      "model_name": "openai/gpt-oss-20b/free",
      "response": "{\"primary_diagnosis\":{\"name\":\"Systemic Lupus Erythematosus with Class III/IV Lupus Nephritis\",\"confidence\":0.85,\"icd_code\":\"M32.4\",\"reasoning\":\"The patient presents with hematuria, proteinuria, RBC casts, and dysmorphic RBCs indicating glomerular bleeding. Low complement C3 and C4, positive ANA 1:160, and elevated ESR/CRP support an immune complex mediated process. The acute rise in creatinine, hypertension, edema, and bilateral renal enlargement are classic for lupus nephritis. The intermittent dysuria and prior antibiotic courses are likely secondary to urinary tract infections, but the systemic findings point to SLE as the underlying etiology.\"},\"differential_diagnoses\":[{\"name\":\"IgA Nephropathy\",\"confidence\":0.25,\"icd_code\":\"N00.4\",\"reasoning\":\"IgA nephropathy can present with hematuria and proteinuria, but it typically does not cause low complement levels or ANA positivity. The presence of low C3/C4 and ANA makes this less likely.\"},{\"name\":\"Post\u2011streptococcal Glomerulonephritis\",\"confidence\":0.15,\"icd_code\":\"N00.0\",\"reasoning\":\"Post\u2011streptococcal GN can cause low C3 but usually has normal C4 and is associated with a recent streptococcal infection, which is not reported.\"},{\"name\":\"Acute Interstitial Nephritis\",\"confidence\":0.10,\"icd_code\":\"N04.1\",\"reasoning\":\"AIN can cause renal dysfunction and eosinophiluria, but RBC casts and dysmorphic RBCs are not typical. Also complement levels are usually normal.\"},{\"name\":\"Membranoproliferative Glomerulonephritis\",\"confidence\":0.10,\"icd_code\":\"N00.6\",\"reasoning\":\"MPGN can present with low complement and proteinuria, but ANA positivity is less common.\"},{\"name\":\"Urinary Tract Infection\",\"confidence\":0.05,\"icd_code\":\"N39.0\",\"reasoning\":\"Urinary symptoms and mixed flora on culture suggest infection, but the systemic findings and renal involvement exceed a simple UTI.\"}],\"key_findings\":[\"Dysmorphic RBCs and RBC casts on urinalysis\",\"Low complement C3 and C4 with positive ANA\",\"Rapidly rising creatinine and bilateral renal enlargement\",\"Hypertension and edema\"],\"diagnostic_tests\":[{\"test\":\"Serum anti\u2011dsDNA antibody\",\"purpose\":\"Confirm SLE activity and correlate with renal disease\",\"priority\":\"urgent\"},{\"test\":\"Renal biopsy\",\"purpose\":\"Determine lupus nephritis class and guide therapy\",\"priority\":\"urgent\"},{\"test\":\"ANCA panel\",\"purpose\":\"Exclude ANCA\u2011associated vasculitis\",\"priority\":\"routine\"},{\"test\":\"Hepatitis B & C serology\",\"purpose\":\"Rule out hepatitis\u2011associated GN\",\"priority\":\"routine\"},{\"test\":\"Urine culture with sensitivity\",\"purpose\":\"Identify and treat any active infection\",\"priority\":\"immediate\"},{\"test\":\"Serum albumin\",\"purpose\":\"Assess hypoalbuminemia and guide ACEi/ARB therapy\",\"priority\":\"routine\"}],\"management_plan\":{\"immediate_actions\":[\"Order urgent anti\u2011dsDNA and renal biopsy\",\"Start empiric high\u2011dose IV methylprednisolone 500 mg daily for 3 days\",\"Initiate ACE inhibitor (lisinopril 10 mg daily) for proteinuria BP control\",\"Provide hydration and monitor urine output\",\"Order repeat urinalysis and serum creatinine in 48 hours\"],\"medications\":[{\"drug\":\"Methylprednisolone\",\"dose\":\"500 mg\",\"route\":\"IV\",\"duration\":\"3 days\",\"rationale\":\"Rapid control of active lupus nephritis\"},{\"drug\":\"Lisinopril\",\"dose\":\"10 mg\",\"route\":\"PO\",\"duration\":\"ongoing\",\"rationale\":\"Reduce proteinuria control hypertension\"},{\"drug\":\"Hydroxychloroquine\",\"dose\":\"200 mg\",\"route\":\"PO\",\"duration\":\"ongoing\",\"rationale\":\"Disease\u2011modifying therapy for SLE\"},{\"drug\":\"Probenecid\",\"dose\":\"250 mg\",\"route\":\"PO\",\"duration\":\"as needed\",\"rationale\":\"Prevent uric acid nephropathy if hyperuricemia develops\"}],\"monitoring\":[\"Serum creatinine and eGFR\",\"Urine protein/creatinine ratio\",\"Blood pressure\",\"CBC (for steroid side effects)\",\"Serum electrolytes (especially potassium)\"],\"consultations\":[{\"specialty\":\"Nephrology\",\"urgency\":\"immediate\",\"reason\":\"Renal biopsy and management of lupus nephritis\"},{\"specialty\":\"Rheumatology\",\"urgency\":\"immediate\",\"reason\":\"Confirm SLE diagnosis and initiate disease\u2011modifying therapy\"}]},\"red_flags\":[\"Rapidly rising creatinine (>0.5 mg/dL in 48 hrs)\",\"Severe hypertension (>180/110 mmHg)\",\"Active urinary sediment with >50 RBC/hpf\",\"Systemic symptoms (fever, rash, arthritis)\",\"Signs of infection (fever, chills)\"],\"patient_education\":[\"Take medications exactly as prescribed; do not skip doses of steroids or hydroxychloroquine\",\"Maintain adequate hydration; avoid NSAIDs and nephrotoxic drugs\",\"Monitor for signs of infection (fever, chills) and report promptly\",\"Keep a log of blood pressure and urine output\",\"Attend all follow\u2011up appointments and labs\"],\"follow_up\":{\"timing\":\"2 weeks for repeat labs and clinical assessment; 1 month for nephrology review\",\"conditions\":\"Return sooner if worsening edema, hypertension, decreased urine output, or new systemic symptoms\"},\"confidence_in_assessment\":0.85,\"uncertainties\":[\"Exact lupus nephritis class (needs biopsy), potential need for additional immunosuppressants (e.g., mycophenolate mofetil)\",\"Differential diagnosis of other complement\u2011consuming GN (e.g., MPGN) cannot be excluded without biopsy\"]}",
      "response_time": 1.0,
      "cached": true,
      "case_id": "Case_13",
      "timestamp": "2025-08-11T22:00:01.045171",
      "tokens_used": 3086,
      "input_tokens": 0,
      "output_tokens": 0
    },
    {
      "model_name": "mistralai/mistral-7b-instruct/free",
      "response": " {\n    \"primary_diagnosis\": {\n        \"name\": \"IgA Nephropathy (Berger's Disease)\",\n        \"confidence\": 0.8,\n        \"icd_code\": \"B23.0\",\n        \"reasoning\": \"The patient's symptoms of hematuria, proteinuria, and renal dysfunction, along with the positive ANA and low C3 and C4 levels, suggest a glomerular disease. The patient's Middle Eastern ethnicity and history of recurrent kidney stones may be relevant risk factors. The normal renal ultrasound and non-contrast CT scan do not rule out glomerular disease as the primary diagnosis.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Renal Cell Carcinoma\",\n            \"confidence\": 0.2,\n            \"icd_code\": \"C64.9\",\n            \"reasoning\": \"The patient's symptoms, along with the bilateral renal enlargement on imaging, could potentially suggest a renal mass. However, the absence of hydronephrosis and the negative urine culture argue against this diagnosis.\"\n        },\n        {\n            \"name\": \"Pyelonephritis\",\n            \"confidence\": 0.1,\n            \"icd_code\": \"N10.9\",\n            \"reasoning\": \"The patient's history of recurrent urinary symptoms and positive urinalysis findings could suggest a urinary tract infection. However, the lack of fever, temporary improvement with antibiotics, and normal urine culture on multiple occasions argue against this diagnosis.\"\n        }\n    ],\n    \"key_findings\": [\"Hematuria\", \"Proteinuria\", \"Renal dysfunction\", \"Bilateral renal enlargement\", \"Positive ANA\", \"Low C3 and C4 levels\"],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Renal biopsy\",\n            \"purpose\": \"To confirm the diagnosis of IgA Nephropathy and assess the severity of the disease\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Anti-dsDNA and ANCA\",\n            \"purpose\": \"To further evaluate for other glomerular diseases\",\n            \"priority\": \"routine\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\"Refer to a nephrologist\", \"Initiate ACE inhibitor therapy to control blood pressure and protect the kidneys\"],\n        \"medications\": [\n            {\n                \"drug\": \"Lisinopril\",\n                \"dose\": \"5mg daily\",\n                \"route\": \"Oral\",\n                \"duration\": \"Long-term\",\n                \"rationale\": \"To control blood pressure and protect the kidneys\"\n            }\n        ],\n        \"monitoring\": [\"Blood pressure\", \"Creatinine level\", \"Proteinuria\"],\n        \"consultations\": [\n            {\n                \"specialty\": \"Nephrology\",\n                \"urgency\": \"immediate\",\n                \"reason\": \"To confirm the diagnosis and manage the disease\"\n            }\n        ]\n    },\n    \"red_flags\": [\"Worsening renal function\", \"Hypertensive emergency\"],\n    \"patient_education\": [\"Avoid NSAIDs as they can worsen kidney function\", \"Maintain a healthy diet and lifestyle to slow the progression of kidney disease\"],\n    \"follow_up\": {\n        \"timing\": \"1 month after nephrology consultation\",\n        \"conditions\": \"Worsening symptoms, rapidly declining kidney function\"\n    },\n    \"confidence_in_assessment\": 0.8,\n    \"uncertainties\": [\"The patient's history of recurrent kidney stones may be a confounding factor\", \"The absence of hydronephrosis and stones on imaging does not completely rule out other renal diseases\"]\n}",
      "response_time": 1.0,
      "cached": true,
      "case_id": "Case_13",
      "timestamp": "2025-08-11T21:23:29.271062",
      "tokens_used": 2483,
      "input_tokens": 0,
      "output_tokens": 0
    },
    {
      "model_name": "anthropic/claude-3.5-sonnet-20241022",
      "response": "{\n  \"primary_diagnosis\": \"IgA Nephropathy vs. Lupus Nephritis\",\n  \"differential_diagnoses\": [\n    \"IgA Nephropathy\",\n    \"Lupus Nephritis Class III/IV\",\n    \"Post-infectious Glomerulonephritis\",\n    \"ANCA-associated Vasculitis\",\n    \"Thin Basement Membrane Disease\",\n    \"Chemical-induced Nephropathy\"\n  ],\n  \"key_findings\": [\n    \"Young male with recurrent hematuria and proteinuria\",\n    \"Dysmorphic RBCs and RBC casts\",\n    \"Declining renal function (eGFR 42)\",\n    \"Low complement levels (C3, C4)\",\n    \"Positive ANA\",\n    \"Bilateral renal enlargement on imaging\",\n    \"Occupational exposure to chemicals\",\n    \"Family history of kidney disease\"\n  ],\n  \"diagnostic_tests\": [\n    \"Renal biopsy (urgent)\",\n    \"Complete serologic workup including anti-dsDNA, ANCA\",\n    \"24-hour urine protein collection\",\n    \"Anti-PLA2R antibodies\",\n    \"Anti-GBM antibodies\",\n    \"Hepatitis B/C screening\",\n    \"Chemical exposure assessment\"\n  ],\n  \"management_plan\": {\n    \"immediate_actions\": [\n      \"Nephrology consultation\",\n      \"Blood pressure control\",\n      \"Fluid status monitoring\",\n      \"Occupational exposure prevention\"\n    ],\n    \"medications\": [\n      \"Consider empiric corticosteroids after biopsy\",\n      \"ACE inhibitor or ARB for proteinuria/hypertension\",\n      \"Hold nephrotoxic medications\"\n    ]\n  },\n  \"red_flags\": [\n    \"Rapidly declining renal function\",\n    \"Significant proteinuria\",\n    \"Hypertension in young patient\",\n    \"Low complement levels\",\n    \"Chemical exposure risk\"\n  ],\n  \"patient_education\": [\n    \"Importance of medication adherence\",\n    \"Blood pressure monitoring\",\n    \"Dietary sodium restriction\",\n    \"Occupational safety measures\",\n    \"Regular follow-up importance\"\n  ],\n  \"follow_up\": {\n    \"timing\": \"Weekly initially\",\n    \"monitoring\": [\n      \"Renal function\",\n      \"Urinalysis\",\n      \"Blood pressure\",\n      \"Complement levels\",\n      \"Proteinuria quantification\"\n    ]\n  },\n  \"confidence_in_assessment\": 0.8,\n  \"uncertainties\": [\n    \"Impact of chemical exposure\",\n    \"Baseline renal function unknown\",\n    \"Complete family history unavailable\",\n    \"Previous stone disease documentation lacking\",\n    \"Pending critical lab results\"\n  ]\n}",
      "response_time": 1.0,
      "cached": true,
      "case_id": "Case_13",
      "timestamp": "2025-08-11T21:31:26.420017",
      "tokens_used": 0,
      "input_tokens": 0,
      "output_tokens": 0
    },
    {
      "model_name": "perplexity/sonar-deep-research",
      "response": "This is a complex case involving a 24-year-old Iranian male with a 6-month history of intermittent hematuria and dysuria, now presenting with acute kidney injury, hypertension, edema, and laboratory findings suggestive of glomerulonephritis.\n\nLet me analyze the key findings:\n\n1. Clinical presentation:\n- 6 months of intermittent gross hematuria and dysuria\n- Recent development of AKI, hypertension, edema, weight gain\n- Young male of Middle Eastern descent\n- Family history of \"kidney problems\"\n\n2. Laboratory findings:\n- Elevated creatinine (2.1 mg/dL) and BUN (45 mg/dL) with reduced eGFR (42)\n- Urinalysis showing: proteinuria (3+), hematuria (3+), dysmorphic RBCs, RBC casts\n- Hypocomplementemia: Low C3 (45) and C4 (8)\n- Positive ANA 1:160 homogeneous pattern\n- Pending anti-dsDNA and ANCA results\n\n3. Physical findings:\n- Hypertension (145/92)\n- Periorbital edema\n- Bilateral CVA tenderness\n- Lower extremity edema\n\nBased on the search results provided, this presentation is most consistent with glomerulonephritis. Let me consider the different types:\n\nFrom the search results, I can see several key patterns:\n\n1. Lupus nephritis [1][4][15][18]:\n- Can present with hematuria, proteinuria, hypertension, edema\n- Associated with positive ANA and anti-dsDNA antibodies\n- Hypocomplementemia (low C3 and C4) is common\n- More common in women, but can occur in men\n- Anti-dsDNA is highly specific for SLE\n\n2. ANCA-associated vasculitis [3][6][12][16][17]:\n\n\nI see this type of glomerulonephritis involves rapid progression of kidney damage with potential systemic inflammation. While less likely given the hypocomplementemia, it remains an important differential diagnosis. The pending ANCA results will provide crucial diagnostic information. The patient's young age and specific clinical features suggest we need to carefully evaluate this possibility.\n\n3. Post-infectious glomerulonephritis [7][9][10]:\nThis type aligns closely with the patient's low complement levels, particularly the significantly reduced C3. While typically seen in children, adult cases do occur. The hypocomplementemia pattern matches the patient's lab results, with low C3 being a hallmark of this condition.\n\n4. IgA nephropathy [8][11][14]:\nI'll need to investigate this further as a potential underlying cause, considering its prevalence as the most common form of glomerulonephritis.\n\nThe episodic hematuria and normal complement levels suggest potential respiratory infection involvement. These findings require careful correlation with the patient's overall clinical picture and additional diagnostic testing.\n\nImmunosuppressive therapy may be indicated, contingent on comprehensive test results. I'll need to carefully evaluate the risk-benefit profile before initiating treatment, ensuring a targeted approach that addresses the underlying pathophysiology while minimizing potential complications.\n\n---\n\n{\n    \"primary_diagnosis\": {\n        \"name\": \"Lupus nephritis\",\n        \"confidence\": 0.75,\n        \"icd_code\": \"M32.14\",\n        \"reasoning\": \"Combination of positive ANA with homogeneous pattern, hypocomplementemia (low C3 and C4), glomerular hematuria with RBC casts, proteinuria, and acute kidney injury in young adult strongly suggests lupus nephritis despite male gender\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Post-infectious glomerulonephritis\",\n            \"confidence\": 0.60,\n            \"icd_code\": \"N05.9\",\n            \"reasoning\": \"Hypocomplementemia, glomerular pattern hematuria, and AKI could indicate post-infectious GN, though positive ANA and 6-month duration make this less likely\"\n        },\n        {\n            \"name\": \"ANCA-associated vasculitis\",\n            \"confidence\": 0.45,\n            \"icd_code\": \"M31.30\",\n            \"reasoning\": \"Rapidly progressive glomerulonephritis pattern with AKI, though typically associated with normal complement levels. ANCA results pending\"\n        },\n        {\n            \"name\": \"IgA nephropathy\",\n            \"confidence\": 0.35,\n            \"icd_code\": \"N02.9\",\n            \"reasoning\": \"Episodes of gross hematuria in young male could suggest IgA nephropathy, but hypocomplementemia and positive ANA make this less likely\"\n        }\n    ],\n    \"key_findings\": [\n        \"Hypocomplementemia with both low C3 (45 mg/dL) and C4 (8 mg/dL)\",\n        \"Positive ANA 1:160 homogeneous pattern\",\n        \"Dysmorphic RBCs with RBC casts indicating glomerular bleeding\",\n        \"Acute kidney injury with creatinine 2.1 mg/dL and eGFR 42\",\n        \"Nephritic syndrome with proteinuria, hematuria, hypertension, and edema\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Anti-dsDNA antibodies\",\n            \"purpose\": \"Confirm systemic lupus erythematosus diagnosis\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"ANCA (c-ANCA/PR3 and p-ANCA/MPO)\",\n            \"purpose\": \"Rule out ANCA-associated vasculitis\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Anti-Sm antibodies, ENA panel\",\n            \"purpose\": \"Further characterize lupus-specific antibodies\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Renal biopsy\",\n            \"purpose\": \"Definitive diagnosis and classification of glomerulonephritis\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"24-hour urine protein and creatinine clearance\",\n            \"purpose\": \"Quantify proteinuria and assess renal function\",\n            \"priority\": \"urgent\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Hold ACE inhibitors/ARBs if taking due to AKI\",\n            \"Strict blood pressure monitoring and control\",\n            \"Daily weights and fluid balance monitoring\",\n            \"Consider nephrotoxin avoidance\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Lisinopril\",\n                \"dose\": \"5 mg\",\n                \"route\": \"PO\",\n                \"duration\": \"Daily, titrate as tolerated\",\n                \"rationale\": \"Blood pressure control and renoprotection once AKI stabilizes\"\n            },\n            {\n                \"drug\": \"Prednisone\",\n                \"dose\": \"1 mg/kg (hold pending nephrology consultation)\",\n                \"route\": \"PO\",\n                \"duration\": \"To be determined\",\n                \"rationale\": \"Immunosuppression for suspected lupus nephritis\"\n            }\n        ],\n        \"monitoring\": [\n            \"Daily creatinine and electrolytes\",\n            \"Daily weights and blood pressure\",\n            \"Weekly CBC, comprehensive metabolic panel\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Nephrology\",\n                \"urgency\": \"immediate\",\n                \"reason\": \"Acute kidney injury with suspected glomerulonephritis requiring urgent evaluation and possible biopsy\"\n            },\n            {\n                \"specialty\": \"Rheumatology\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"Suspected systemic lupus erythematosus requiring specialized management\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Rapidly progressive deterioration in renal function\",\n        \"Severe hypertension or hypertensive emergency\",\n        \"Pulmonary edema or congestive heart failure\",\n        \"Oliguria or anuria\",\n        \"Signs of systemic lupus flare (fever, rash, joint pain)\"\n    ],\n    \"patient_education\": [\n        \"Explain need for urgent nephrology evaluation and possible kidney biopsy\",\n        \"Discuss potential diagnosis of autoimmune kidney disease\",\n        \"Emphasize importance of medication compliance and follow-up\",\n        \"Advise to avoid nephrotoxic medications including NSAIDs\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"Nephrology within 24-48 hours, primary care within 1 week\",\n        \"conditions\": \"Return immediately for worsening shortness of breath, decreased urination, severe headache, or chest pain\"\n    },\n    \"confidence_in_assessment\": 0.75,\n    \"uncertainties\": [\n        \"Pending anti-dsDNA and ANCA results will significantly influence final diagnosis\",\n        \"Unusual presentation of lupus in young male patient\",\n        \"Need for renal biopsy to definitively classify glomerulonephritis type\",\n        \"Unclear baseline renal function complicates assessment of acuity\"\n    ]\n}",
      "response_time": 65.98812532424927,
      "cached": true,
      "case_id": "Case_13",
      "timestamp": "2025-08-11T22:14:38.484708",
      "tokens_used": 3405,
      "input_tokens": 1445,
      "output_tokens": 1960
    },
    {
      "model_name": "ai21/jamba-large-1.7",
      "response": "{\n    \"primary_diagnosis\": {\n        \"name\": \"Lupus Nephritis\",\n        \"confidence\": 0.85,\n        \"icd_code\": \"M32.14\",\n        \"reasoning\": \"The patient's presentation, including hematuria, proteinuria, bilateral flank pain, low C3 and C4 levels, and positive ANA with a homogeneous pattern, strongly suggests lupus nephritis. The patient's history of recurrent kidney stones, which could have been misdiagnosed, also supports this diagnosis. The decreased kidney function (eGFR 42 mL/min/1.73m\u00b2) and elevated creatinine (2.1 mg/dL) further indicate renal involvement.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"IgA Nephropathy (Berger's Disease)\",\n            \"confidence\": 0.65,\n            \"icd_code\": \"N02.0\",\n            \"reasoning\": \"IgA nephropathy presents with hematuria, often following an upper respiratory infection (not reported here). The dysmorphic RBCs and RBC casts in the urine suggest a glomerular source of bleeding, which can be seen in IgA nephropathy. However, the absence of recent upper respiratory symptoms and the presence of bilateral flank pain and low C3 and C4 levels make lupus nephritis more likely.\"\n        },\n        {\n            \"name\": \"Membranous Nephropathy\",\n            \"confidence\": 0.50,\n            \"icd_code\": \"N03.2\",\n            \"reasoning\": \"Membranous nephropathy could explain the proteinuria and hematuria, but it typically presents with nephrotic syndrome (significant proteinuria, hypoalbuminemia, hyperlipidemia, and edema), which is not fully described in this patient. The absence of severe edema and hyperlipidemia makes this diagnosis less likely.\"\n        },\n        {\n            \"name\": \"Post-Streptococcal Glomerulonephritis (PSGN)\",\n            \"confidence\": 0.40,\n            \"icd_code\": \"N05.0\",\n            \"reasoning\": \"PSGN is characterized by hematuria, proteinuria, and low C3 levels. However, this condition is more common in children and typically follows a streptococcal infection. The patient's reported sexual activity and travel history do not suggest recent streptococcal infection, making this diagnosis less likely.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Hematuria with dysmorphic RBCs and RBC casts\",\n        \"Low C3 and C4 levels\",\n        \"Positive ANA with homogeneous pattern\",\n        \"Bilateral renal enlargement on imaging\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Renal biopsy\",\n            \"purpose\": \"Confirm lupus nephritis and differentiate from other glomerular diseases\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Anti-dsDNA antibodies\",\n            \"purpose\": \"Support the diagnosis of systemic lupus erythematosus (SLE)\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Urinalysis and microscopy during asymptomatic periods\",\n            \"purpose\": \"Assess for persistent glomerular abnormalities\",\n            \"priority\": \"routine\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Initiate antihypertensive therapy (ACE inhibitor or ARB) to manage blood pressure and reduce proteinuria\",\n            \"Refer to nephrology for further evaluation and management\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Lisinopril\",\n                \"dose\": \"10 mg daily\",\n                \"route\": \"PO\",\n                \"duration\": \"Indefinitely\",\n                \"rationale\": \"To control hypertension and reduce proteinuria\"\n            }\n        ],\n        \"monitoring\": [\n            \"Monitor kidney function (serum creatinine, eGFR) every 2 weeks initially, then monthly\",\n            \"Monitor for side effects of ACE inhibitors (hyperkalemia, worsening renal function)\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Nephrology\",\n                \"urgency\": \"immediate\",\n                \"reason\": \"Evaluate and manage lupus nephritis and renal dysfunction\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Rapidly progressive decline in kidney function (e.g., further increase in creatinine)\",\n        \"Severe hypertension (BP >160/100 mmHg)\",\n        \"Signs of systemic lupus activity (e.g., rash, joint pain, fever)\"\n    ],\n    \"patient_education\": [\n        \"Explanation of lupus nephritis and its potential impact on kidney function\",\n        \"Importance of medication adherence and regular follow-up\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"Follow up with nephrology within 1-2 weeks\",\n        \"conditions\": \"Return immediately if symptoms worsen (e.g., increased flank pain, decreased urine output, severe swelling)\"\n    },\n    \"confidence_in_assessment\": 0.85,\n    \"uncertainties\": [\n        \"Exact etiology of kidney dysfunction without renal biopsy results\",\n        \"Pending anti-dsDNA and ANCA results\"\n    ]\n}",
      "response_time": 26.51743483543396,
      "cached": true,
      "case_id": "Case_13",
      "timestamp": "2025-08-11T21:32:55.267069",
      "tokens_used": 3005,
      "input_tokens": 1698,
      "output_tokens": 1307
    },
    {
      "model_name": "google/gemini-2.5-flash-lite",
      "response": "```json\n{\n    \"primary_diagnosis\": {\n        \"name\": \"Lupus Nephritis (Class III or IV)\",\n        \"confidence\": 0.9,\n        \"icd_code\": \"N04.1\",\n        \"reasoning\": \"The patient presents with a constellation of symptoms and laboratory findings highly suggestive of lupus nephritis: active urinary sediment with dysmorphic RBCs and RBC casts, significant proteinuria (3+), elevated creatinine and BUN indicating renal dysfunction, and systemic inflammatory markers (elevated ESR and CRP). The positive ANA and low complement levels (C3 and C4) are classic serological markers for Systemic Lupus Erythematosus (SLE), which frequently involves the kidneys. The bilateral flank pain, edema, and weight gain are also consistent with acute kidney injury secondary to inflammatory renal disease. The intermittent nature of the initial urinary symptoms could represent flares of lupus activity.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"IgA Nephropathy\",\n            \"confidence\": 0.4,\n            \"icd_code\": \"N02.2\",\n            \"reasoning\": \"Can present with recurrent gross hematuria and proteinuria, often triggered by infections. However, the presence of systemic symptoms, positive ANA, and low complement levels make it less likely than lupus nephritis.\"\n        },\n        {\n            \"name\": \"Post-infectious Glomerulonephritis\",\n            \"confidence\": 0.3,\n            \"icd_code\": \"N03.0\",\n            \"reasoning\": \"Can cause hematuria, proteinuria, and acute kidney injury. However, typically follows a preceding infection (e.g., streptococcal), and the serological markers (ANA, complement) are not characteristic.\"\n        },\n        {\n            \"name\": \"Recurrent Urinary Tract Infection with Interstitial Nephritis\",\n            \"confidence\": 0.2,\n            \"icd_code\": \"N39.0\",\n            \"reasoning\": \"The initial symptoms of burning and blood could be attributed to UTIs, and the history of antibiotic treatment supports this. However, the current presentation with significant renal dysfunction, proteinuria, RBC casts, and systemic lupus markers makes a simple UTI unlikely as the primary cause of the worsening renal failure. Interstitial nephritis could be considered, but the specific serology points away from this.\"\n        },\n        {\n            \"name\": \"Drug-induced Lupus\",\n            \"confidence\": 0.2,\n            \"icd_code\": \"M32.10\",\n            \"reasoning\": \"While possible given the patient's doctoral studies involving chemicals, the absence of a clear offending drug (other than sertraline, which is not a common culprit for lupus-like syndrome with nephritis) and the typical presentation of SLE make idiopathic lupus more probable. The history of recurrent 'kidney stones' as a teenager could also be related to underlying metabolic issues or early signs of renal disease.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Gross hematuria with dysmorphic RBCs and RBC casts\",\n        \"Significant proteinuria (3+)\",\n        \"Elevated serum creatinine and BUN with reduced eGFR\",\n        \"Positive ANA with homogeneous pattern\",\n        \"Low serum C3 and C4 complement levels\",\n        \"Bilateral flank pain, periorbital edema, and pitting edema\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Anti-dsDNA antibody\",\n            \"purpose\": \"Highly specific for SLE and often correlates with lupus nephritis activity.\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"ANCA (Anti-neutrophil cytoplasmic antibodies)\",\n            \"purpose\": \"To rule out vasculitis, though less likely given other findings.\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Kidney Biopsy\",\n            \"purpose\": \"Gold standard for diagnosing and staging lupus nephritis, guiding treatment.\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"24-hour Urine Protein Collection\",\n            \"purpose\": \"Quantify proteinuria for accurate staging and monitoring.\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Urine electrolytes and creatinine\",\n            \"purpose\": \"To assess for intrinsic renal disease vs. pre-renal causes of azotemia.\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Complete Urinalysis and Urine Culture\",\n            \"purpose\": \"Monitor for infection and characterize urinary sediment.\",\n            \"priority\": \"routine\"\n        },\n        {\n            \"test\": \"Serum electrolytes, BUN, Creatinine, eGFR\",\n            \"purpose\": \"Monitor renal function.\",\n            \"priority\": \"routine\"\n        },\n        {\n            \"test\": \"CBC with differential\",\n            \"purpose\": \"Assess for anemia, thrombocytopenia, or leukopenia.\",\n            \"priority\": \"routine\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Admit patient for further evaluation and management of acute kidney injury.\",\n            \"Initiate intravenous hydration if signs of dehydration.\",\n            \"Strict intake and output monitoring.\",\n            \"Low sodium diet.\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Methylprednisolone IV (high-dose)\",\n                \"dose\": \"1000 mg daily for 3 days, then transition to oral prednisone\",\n                \"route\": \"IV\",\n                \"duration\": \"3 days\",\n                \"rationale\": \"To suppress acute inflammation in lupus nephritis.\"\n            },\n            {\n                \"drug\": \"Prednisone\",\n                \"dose\": \"1 mg/kg/day orally, to be tapered based on response and biopsy results\",\n                \"route\": \"PO\",\n                \"duration\": \"Indefinite, with slow taper\",\n                \"rationale\": \"Corticosteroid therapy for lupus nephritis.\"\n            },\n            {\n                \"drug\": \"Mycophenolate Mofetil (MMF)\",\n                \"dose\": \"500 mg PO BID, to be increased to 1000 mg PO BID\",\n                \"route\": \"PO\",\n                \"duration\": \"Indefinite\",\n                \"rationale\": \"Immunosuppressant therapy to induce remission and prevent relapse, often used in combination with corticosteroids for lupus nephritis.\"\n            }\n        ],\n        \"monitoring\": [\n            \"Renal function (creatinine, BUN, eGFR) daily.\",\n            \"Urinalysis (hematuria, proteinuria, casts) every other day.\",\n            \"Blood pressure and fluid status (edema, weight) daily.\",\n            \"Electrolytes daily.\",\n            \"Clinical symptoms (dysuria, flank pain, fatigue) daily.\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Nephrology\",\n                \"urgency\": \"immediate\",\n                \"reason\": \"Diagnosis and management of lupus nephritis and acute kidney injury.\"\n            },\n            {\n                \"specialty\": \"Rheumatology\",\n                \"urgency\": \"immediate\",\n                \"reason\": \"Diagnosis and management of underlying Systemic Lupus Erythematosus.\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Progressive renal dysfunction (rising creatinine)\",\n        \"Significant proteinuria\",\n        \"Systemic lupus serology (positive ANA, low complement)\",\n        \"Bilateral flank pain and edema indicating potential worsening renal compromise.\"\n    ],\n    \"patient_education\": [\n        \"Explanation of lupus nephritis and its potential impact on kidney function.\",\n        \"Importance of adherence to immunosuppressive medications and timely follow-up.\",\n        \"Discussion of potential side effects of corticosteroid and immunosuppressive therapy.\",\n        \"Need for ongoing monitoring of blood pressure and fluid balance.\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"Weekly for the first month, then monthly visits with nephrology and rheumatology.\",\n        \"conditions\": \"Any increase in creatinine, significant worsening of edema, persistent fever, or uncontrolled blood pressure requires immediate return.\"\n    },\n    \"confidence_in_assessment\": 0.9,\n    \"uncertainties\": [\n        \"The exact class of lupus nephritis (will be determined by biopsy).\",\n        \"The potential role of environmental exposures (e.g., solvents from his PhD work) in precipitating or exacerbating SLE.\",\n        \"The specific 'kidney problems' in the family history and their potential genetic implications.\",\n        \"The long-term prognosis and response to treatment.\"\n    ]\n}\n```",
      "response_time": 6.353575944900513,
      "cached": true,
      "case_id": "Case_13",
      "timestamp": "2025-08-11T21:26:09.532495",
      "tokens_used": 3470,
      "input_tokens": 1554,
      "output_tokens": 1916
    },
    {
      "model_name": "mistralai/mistral-large-2411",
      "response": "```json\n{\n    \"primary_diagnosis\": {\n        \"name\": \"IgA Nephropathy\",\n        \"confidence\": 0.8,\n        \"icd_code\": \"N08.0\",\n        \"reasoning\": \"Chronic hematuria, dysmorphic RBCs, proteinuria, low complement levels, and bilateral renal enlargement suggest glomerulonephritis. IgA nephropathy is the most common glomerulonephritis worldwide and fits with the patient's age and symptoms.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Lupus Nephritis\",\n            \"confidence\": 0.6,\n            \"icd_code\": \"M32.14\",\n            \"reasoning\": \"Positive ANA, low complement levels, and proteinuria are consistent with lupus nephritis. However, the patient's age and sex make this less likely.\"\n        },\n        {\n            \"name\": \"Post-Infectious Glomerulonephritis\",\n            \"confidence\": 0.5,\n            \"icd_code\": \"N05.9\",\n            \"reasoning\": \"History of recurrent infections and hematuria could suggest post-infectious glomerulonephritis, but the chronic nature of symptoms makes this less likely.\"\n        },\n        {\n            \"name\": \"Alport Syndrome\",\n            \"confidence\": 0.3,\n            \"icd_code\": \"Q87.89\",\n            \"reasoning\": \"Family history of 'kidney problems' and hematuria could suggest Alport syndrome, but the late onset and lack of hearing loss make this less likely.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Chronic hematuria with dysmorphic RBCs\",\n        \"Proteinuria\",\n        \"Bilateral renal enlargement\",\n        \"Low complement levels\",\n        \"Positive ANA\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Renal Biopsy\",\n            \"purpose\": \"Confirm glomerulonephritis and determine type\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Serum IgA levels\",\n            \"purpose\": \"Support diagnosis of IgA nephropathy\",\n            \"priority\": \"routine\"\n        },\n        {\n            \"test\": \"Anti-dsDNA and ANCA results\",\n            \"purpose\": \"Rule out lupus nephritis and vasculitis\",\n            \"priority\": \"routine\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Admit for further evaluation and management\",\n            \"Initiate renal-protective measures\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Prednisone\",\n                \"dose\": \"60 mg daily\",\n                \"route\": \"PO\",\n                \"duration\": \"6 weeks, then taper\",\n                \"rationale\": \"Reduce inflammation and protect renal function\"\n            },\n            {\n                \"drug\": \"Lisinopril\",\n                \"dose\": \"10 mg daily\",\n                \"route\": \"PO\",\n                \"duration\": \"Indefinite\",\n                \"rationale\": \"Reduce proteinuria and slow progression of renal disease\"\n            }\n        ],\n        \"monitoring\": [\n            \"Renal function and proteinuria\",\n            \"Every 2 weeks initially, then as needed\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Nephrology\",\n                \"urgency\": \"immediate\",\n                \"reason\": \"Specialist management of glomerulonephritis\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Rapidly worsening renal function\",\n        \"Severe hypertension\",\n        \"New-onset edema or weight gain\"\n    ],\n    \"patient_education\": [\n        \"Avoid non-steroidal anti-inflammatory drugs (NSAIDs)\",\n        \"Monitor blood pressure and renal function regularly\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"2 weeks\",\n        \"conditions\": \"Worsening symptoms, new-onset edema, or significant weight gain\"\n    },\n    \"confidence_in_assessment\": 0.8,\n    \"uncertainties\": [\n        \"Exact etiology of glomerulonephritis\",\n        \"Baseline renal function\",\n        \"Family history of kidney disease\"\n    ]\n}\n```",
      "response_time": 21.18046474456787,
      "cached": true,
      "case_id": "Case_13",
      "timestamp": "2025-08-11T21:26:38.325417",
      "tokens_used": 2973,
      "input_tokens": 1815,
      "output_tokens": 1158
    },
    {
      "model_name": "cohere/command-r-plus",
      "response": "{\n  \"primary_diagnosis\": \"Intermittent hematuria with dysuria, likely glomerulonephritis with a possibility of an autoimmune etiology, and bilateral renal enlargement.\",\n  \"differential_diagnoses\": [\n    \"IgA nephropathy (most common glomerulonephritis worldwide)\", \n    \"Lupus nephritis (especially with positive ANA)\", \n    \"Post-infectious glomerulonephritis (PIGN)\", \n    \"Anti-glomerular basement membrane (GBM) disease (given the rapid decline in renal function)\", \n    \"Membranous nephropathy (with autoimmune features)\", \n    \"Thin basement membrane disease (TBMD)\", \n    \"Chronic interstitial nephritis (given chemical exposure)\"\n  ],\n  \"key_findings\": [\n    \"Intermittent gross hematuria with dysuria, resolving completely between episodes.\", \n    \"Elevated creatinine, reduced eGFR, and bilateral renal enlargement on imaging.\", \n    \"Positive ANA, low C3 and C4 levels, indicating an autoimmune process.\", \n    \"Proteinuria, RBC casts, and elevated ESR suggest glomerular inflammation.\", \n    \"History of kidney stones and family history of kidney problems.\"\n  ],\n  \"diagnostic_tests\": [\n    \"Anti-dsDNA and ANCA tests to evaluate for lupus nephritis or other autoimmune conditions.\", \n    \"Renal biopsy to confirm the type of glomerulonephritis and guide treatment.\", \n    \"Further imaging, such as MRI, to assess renal architecture and blood flow.\", \n    \"Repeat urine culture to rule out chronic or persistent infection.\"\n  ],\n  \"management_plan\": [\n    \"Immediate referral to nephrology for specialized care and monitoring of renal function.\", \n    \"Immunosuppressive therapy, such as corticosteroids, to manage glomerulonephritis and prevent further renal damage.\", \n    \"Close monitoring of blood pressure and management if elevated, to reduce the progression of kidney damage.\", \n    \"Dietary modifications to reduce protein and sodium intake, and manage edema.\", \n    \"Education on fluid intake to ensure adequate hydration without overloading the kidneys.\", \n    \"Psychosocial support to cope with the impact of a chronic kidney condition.\"\n  ],\n  \"red_flags\": [\n    \"Rapid decline in renal function indicated by rising creatinine and falling eGFR.\", \n    \"Autoimmune workup suggests an underlying systemic autoimmune disease.\", \n    \"History of kidney stones and family history of kidney problems indicate a potential genetic predisposition.\"\n  ],\n  \"patient_education\": [\n    \"Explain the nature of glomerulonephritis and the importance of early intervention to prevent kidney damage.\", \n    \"Discuss the potential side effects of immunosuppressive therapy and the need for close monitoring.\", \n    \"Emphasize the importance of adhering to dietary and fluid recommendations.\", \n    \"Provide resources for mental health support and encourage regular exercise within physical limits.\"\n  ],\n  \"follow_up\": [\n    \"Regular nephrology appointments for renal function monitoring and management adjustments.\", \n    \"Repeat laboratory tests and imaging as indicated to assess response to treatment.\", \n    \"Long-term monitoring for potential complications, such as hypertension and edema.\"\n  ],\n  \"confidence_in_assessment\": \"Moderate to high confidence in the primary diagnosis of glomerulonephritis with an autoimmune component. Differential diagnoses are ranked based on likelihood and the patient's presentation.\",\n  \"uncertainties\": [\n    \"Pending anti-dsDNA and ANCA results may alter the likelihood of certain differential diagnoses.\", \n    \"Renal biopsy is required to definitively confirm the type of glomerulonephritis.\", \n    \"The impact of chemical exposure on renal function is unclear and requires further investigation.\"\n  ]\n}",
      "response_time": 1.0,
      "cached": true,
      "case_id": "Case_13",
      "timestamp": "2025-08-11T22:02:56.522992",
      "tokens_used": 0,
      "input_tokens": 0,
      "output_tokens": 0
    },
    {
      "model_name": "microsoft/wizardlm-2-8x22b",
      "response": " ```json\n{\n    \"primary_diagnosis\": {\n        \"name\": \"Rapidly Progressive Glomerulonephritis (RPGN)\",\n        \"confidence\": 0.8,\n        \"icd_code\": \"N00.0\",\n        \"reasoning\": \"The presence of RBC casts, proteinuria, hematuria, and rapid decline in renal function with a history of intermittent symptoms and family history of kidney problems suggest a glomerulonephritis. The low C3 and C4 levels, along with a positive ANA, are indicative of an immune-complex mediated glomerulonephritis, which can progress rapidly.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"IgA Nephropathy\",\n            \"confidence\": 0.6,\n            \"icd_code\": \"N01.1\",\n            \"reasoning\": \"Recurrent gross hematuria, especially in a young male, is common in IgA nephropathy. The absence of stone disease on imaging and the presence of proteinuria support this diagnosis.\"\n        },\n        {\n            \"name\": \"Systemic Lupus Erythematosus (SLE)\",\n            \"confidence\": 0.5,\n            \"icd_code\": \"M32.1\",\n            \"reasoning\": \"Positive ANA with a homogeneous pattern and low complement levels are suggestive of SLE, which can present with glomerulonephritis. The patient's gender and age are consistent with SLE demographics.\"\n        },\n        {\n            \"name\": \"Post-infectious Glomerulonephritis\",\n            \"confidence\": 0.4,\n            \"icd_code\": \"N05.9\",\n            \"reasoning\": \"The recent onset of symptoms and a history of recurrent infections, as suggested by multiple courses of antibiotics, could indicate a post-infectious etiology.\"\n        }\n    ],\n    \"key_findings\": [\n        \"RBC casts on urinalysis\",\n        \"Rapid decline in renal function (elevated creatinine and BUN, reduced eGFR)\",\n        \"Low complement levels (C3 and C4)\",\n        \"Positive ANA\",\n        \"Bilateral renal enlargement on imaging\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Anti-dsDNA antibody\",\n            \"purpose\": \"To further evaluate for SLE\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"ANCA (if not already performed)\",\n            \"purpose\": \"To rule out ANCA-associated vasculitis\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Renal biopsy\",\n            \"purpose\": \"To confirm the specific type of glomerulonephritis and guide treatment\",\n            \"priority\": \"urgent\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Assess volume status and manage fluid overload if present\",\n            \"Control blood pressure if hypertensive\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Prednisone\",\n                \"dose\": \"1 mg/kg/day\",\n                \"route\": \"PO\",\n                \"duration\": \"To be determined based on response and biopsy results\",\n                \"rationale\": \"To reduce inflammation and immune complex deposition in the kidneys\"\n            }\n        ],\n        \"monitoring\": [\n            \"Daily weight, blood pressure, and input/output charting\",\n            \"Regular monitoring of renal function and electrolytes\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Nephrology\",\n                \"urgency\": \"immediate\",\n                \"reason\": \"For management of rapidly declining renal function and potential renal biopsy\"\n            },\n            {\n                \"specialty\": \"Rheumatology\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"For assessment of potential connective tissue disease\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Severe hypertension\",\n        \"Oliguria or anuria\",\n        \"Signs of fluid overload (pulmonary edema, severe peripheral edema)\"\n    ],\n    \"patient_education\": [\n        \"Importance of medication adherence and follow-up\",\n        \"Potential dietary modifications (sodium and fluid restriction as indicated)\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"Within 1 week or sooner based on clinical status\",\n        \"conditions\": \"Worsening renal function, development of severe hypertension, signs of fluid overload, or new neurological symptoms\"\n    },\n    \"confidence_in_assessment\": 0.75,\n    \"uncertainties\": [\n        \"Pending results for Anti-dsDNA and ANCA\",\n        \"Lack of baseline renal function data\",\n        \"Potential environmental exposures related to the patient's occupation that may contribute to renal injury\"\n    ]\n}\n```",
      "response_time": 45.587799072265625,
      "cached": true,
      "case_id": "Case_13",
      "timestamp": "2025-08-11T22:15:24.074694",
      "tokens_used": 3118,
      "input_tokens": 1849,
      "output_tokens": 1269
    },
    {
      "model_name": "x-ai/grok-2-1212",
      "response": "{\n    \"primary_diagnosis\": {\n        \"name\": \"Lupus nephritis\",\n        \"confidence\": 0.8,\n        \"icd_code\": \"M32.14\",\n        \"reasoning\": \"Patient's symptoms of hematuria, proteinuria, and renal dysfunction, combined with low C3 and C4 levels and positive ANA, suggest an autoimmune process affecting the kidneys, most likely lupus nephritis.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"IgA nephropathy\",\n            \"confidence\": 0.6,\n            \"icd_code\": \"N02.8\",\n            \"reasoning\": \"Hematuria and renal dysfunction could be due to IgA nephropathy, though the low complement levels and positive ANA are less typical.\"\n        },\n        {\n            \"name\": \"ANCA-associated vasculitis\",\n            \"confidence\": 0.5,\n            \"icd_code\": \"M31.7\",\n            \"reasoning\": \"Renal involvement and hematuria could be due to vasculitis; pending ANCA results are crucial to rule this in or out.\"\n        },\n        {\n            \"name\": \"Chronic interstitial nephritis\",\n            \"confidence\": 0.4,\n            \"icd_code\": \"N11.9\",\n            \"reasoning\": \"Exposure to chemicals in his work as a chemistry student could contribute to interstitial nephritis, though the autoimmune markers suggest a different etiology.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Intermittent dysuria and gross hematuria for 6 months\",\n        \"New onset of bilateral flank pain, decreased urine output, and weight gain\",\n        \"Low C3 and C4 levels with positive ANA\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Renal biopsy\",\n            \"purpose\": \"To confirm diagnosis and determine class of lupus nephritis\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Anti-dsDNA antibody\",\n            \"purpose\": \"To further support diagnosis of lupus\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"ANCA\",\n            \"purpose\": \"To rule out ANCA-associated vasculitis\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"24-hour urine protein\",\n            \"purpose\": \"To quantify proteinuria and monitor renal function\",\n            \"priority\": \"routine\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Initiate renal protective measures including blood pressure control\",\n            \"Refer to nephrology and rheumatology for further evaluation and management\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Prednisone\",\n                \"dose\": \"1 mg/kg/day\",\n                \"route\": \"PO\",\n                \"duration\": \"Pending biopsy results\",\n                \"rationale\": \"To treat potential lupus nephritis and reduce inflammation\"\n            },\n            {\n                \"drug\": \"Lisinopril\",\n                \"dose\": \"10 mg/day\",\n                \"route\": \"PO\",\n                \"duration\": \"Ongoing\",\n                \"rationale\": \"To manage hypertension and protect renal function\"\n            }\n        ],\n        \"monitoring\": [\n            \"Blood pressure\",\n            \"Daily\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Nephrology\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"For management of renal disease and potential biopsy\"\n            },\n            {\n                \"specialty\": \"Rheumatology\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"For management of potential systemic lupus erythematosus\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Rapidly worsening renal function\",\n        \"Signs of fluid overload or pulmonary edema\"\n    ],\n    \"patient_education\": [\n        \"Importance of adhering to medication regimen and follow-up appointments\",\n        \"Need to monitor for signs of worsening kidney function or other systemic symptoms\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"1 week after initiating treatment\",\n        \"conditions\": \"Worsening symptoms, significant weight gain, or shortness of breath\"\n    },\n    \"confidence_in_assessment\": 0.8,\n    \"uncertainties\": [\n        \"Exact etiology of renal disease pending further testing\",\n        \"Impact of previous chemical exposure on current condition\",\n        \"Lack of detailed family medical history due to recent immigration\"\n    ]\n}",
      "response_time": 10.287477970123291,
      "cached": true,
      "case_id": "Case_13",
      "timestamp": "2025-08-11T22:15:59.896809",
      "tokens_used": 2394,
      "input_tokens": 1461,
      "output_tokens": 933
    },
    {
      "model_name": "google/gemma-2-9b-it",
      "response": "{\n    \"primary_diagnosis\": {\n        \"name\": \"Lupus nephritis\",\n        \"confidence\": 0.7,\n        \"icd_code\": \"N17.0\",\n        \"reasoning\": \"The combination of hematuria, proteinuria, RBC casts, elevated creatinine, decreased eGFR, positive ANA with a homogeneous pattern, low C3 and C4, and bilateral renal enlargement strongly suggests lupus nephritis.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"IgA nephropathy\",\n            \"confidence\": 0.2,\n            \"icd_code\": \"N03.9\",\n            \"reasoning\": \"Persistent hematuria and the presence of RBC casts are consistent with IgA nephropathy. However, the absence of IgA nephropathy in the urinalysis and the positive ANA argue against this diagnosis.\"\n        },\n        {\n            \"name\": \"Polycystic kidney disease\",\n            \"confidence\": 0.1,\n            \"icd_code\": \"E31.1\",\n            \"reasoning\": \"The patient's family history of 'kidney problems' raises the possibility of PKD. However, the ultrasound did not show typical cystic changes, and the clinical presentation is more suggestive of glomerulonephritis.\"\n        },\n        {\n            \"name\": \"Acute interstitial nephritis\",\n            \"confidence\": 0.05,\n            \"icd_code\": \"N17.9\",\n            \"reasoning\": \"The patient's recent antibiotic use could potentially contribute to acute interstitial nephritis. However, the lack of fever and the presence of renal enlargement make this diagnosis less likely.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Gross hematuria with dysmorphic RBCs\",\n        \"Proteinuria with RBC casts\",\n        \"Elevated creatinine and decreased eGFR\",\n        \"Positive ANA with a homogeneous pattern and low complement levels\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Anti-dsDNA antibody\",\n            \"purpose\": \"Confirm lupus diagnosis\",\n            \"priority\": \"Immediate\"\n        },\n        {\n            \"test\": \"ANCA panel\",\n            \"purpose\": \"Rule out ANCA-associated vasculitis\",\n            \"priority\": \"Urgent\"\n        },\n        {\n            \"test\": \"Renal biopsy\",\n            \"purpose\": \"Definitive diagnosis and classification of glomerulonephritis\",\n            \"priority\": \"Urgent\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Hospital admission for close monitoring\",\n            \"Initiation of high-dose corticosteroids\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Prednisone\",\n                \"dose\": \"1mg/kg/day\",\n                \"route\": \"Oral\",\n                \"duration\": \"Indefinitely, tapered as tolerated\",\n                \"rationale\": \"To suppress inflammation and treat active lupus nephritis\"\n            }\n        ],\n        \"monitoring\": [\n            \"Daily blood pressure and weight\",\n            \"Repeat creatinine and eGFR every 2 days\",\n            \"Urine protein and creatinine ratio daily\",\n            \"Complete blood count and electrolytes\",\n            \"Side effects of corticosteroids\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Nephrology\",\n                \"urgency\": \"Immediate\",\n                \"reason\": \"For management of lupus nephritis and renal function monitoring\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Rapidly declining renal function\",\n        \"Development of nephrotic syndrome (significant proteinuria and hypoalbuminemia)\",\n        \"Signs of infection or sepsis\",\n        \"Neurological symptoms\"\n    ],\n    \"patient_education\": [\n        \"Lupus is a chronic autoimmune disease that can affect multiple organs, including the kidneys.\",\n        \"Treatment involves medications to suppress the immune system and manage symptoms.\",\n        \"It's important to follow up regularly with your nephrologist and report any changes in your health.\",\n        \"Lifestyle modifications, such as stress management and sun protection, may also be beneficial.\",\n        \"Information about lupus and support groups can be found through the Lupus Foundation of America.\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"Weekly for the first month, then monthly\",\n        \"conditions\": \"Immediately return if you experience any signs of infection, such as fever, chills, or cough; worsening kidney function, such as decreased urine output or swelling; or new or worsening pain.\"\n    },\n    \"confidence_in_assessment\": 0.7,\n    \"uncertainties\": [\n        \"The exact type of lupus nephritis will require a renal biopsy to confirm.\",\n        \"The long-term prognosis depends on the severity of kidney involvement and the patient's response to treatment.\"\n    ]\n} \n",
      "response_time": 2.7365639209747314,
      "cached": true,
      "case_id": "Case_13",
      "timestamp": "2025-08-11T21:26:12.366079",
      "tokens_used": 2653,
      "input_tokens": 1563,
      "output_tokens": 1090
    },
    {
      "model_name": "google/gemma-3-4b-it/free",
      "response": "```json\n{\n    \"primary_diagnosis\": {\n        \"name\": \"Systemic Lupus Erythematosus (SLE) with Nephritis\",\n        \"confidence\": 0.85,\n        \"icd_code\": \"M32.0\",\n        \"reasoning\": \"The patient presents with a constellation of symptoms suggestive of SLE, including dysuria, hematuria, flank pain, decreased urine output, weight gain, bilateral C3 and C4 complement deficiencies, proteinuria, positive ANA with a homogeneous pattern, and ESR elevation. The renal ultrasound and CT findings of bilateral renal enlargement are consistent with lupus nephritis. The recurrent urinary tract infections, while treated with antibiotics, suggest an underlying immune dysregulation. The periorbital edema and fatigue further support the diagnosis.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"IgA Nephropathy\",\n            \"confidence\": 0.20,\n            \"icd_code\": \"N03.0\",\n            \"reasoning\": \"Recurrent kidney stones in the past could suggest IgA nephropathy. However, the presence of proteinuria, complement deficiencies, ANA positivity, and flank pain make SLE more likely.\"\n        },\n        {\n            \"name\": \"Pyelonephritis\",\n            \"confidence\": 0.15,\n            \"icd_code\": \"N39.0\",\n            \"reasoning\": \"While the initial urine culture was negative, recurrent episodes of dysuria and hematuria could represent pyelonephritis. However, the persistent symptoms, proteinuria, and autoimmune markers point away from a simple bacterial infection.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Dysuria and gross hematuria\",\n        \"Bilateral flank pain and decreased urine output\",\n        \"Proteinuria (3+)\",\n        \"Low C3 and C4 complement levels\",\n        \"Positive ANA with homogeneous pattern\",\n        \"Elevated ESR and CRP\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Anti-dsDNA antibody testing\",\n            \"purpose\": \"To further evaluate for SLE and assess disease activity\",\n            \"priority\": \"Urgent\"\n        },\n        {\n            \"test\": \"Renal Biopsy\",\n            \"purpose\": \"To confirm lupus nephritis, determine the stage of disease, and assess renal function\",\n            \"priority\": \"Urgent\"\n        },\n        {\n            \"test\": \"Repeat urine culture\",\n            \"purpose\": \"To rule out persistent bacterial infection\",\n            \"priority\": \"Routine\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Initiate intravenous fluids for hydration\",\n            \"Start empiric immunosuppression (e.g., corticosteroids) pending biopsy results\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Prednisone\",\n                \"dose\": \"10mg daily\",\n                \"route\": \"Oral\",\n                \"duration\": \"Initially 1-2mg daily, tapering as tolerated\",\n                \"rationale\": \"To suppress the immune system and reduce inflammation\"\n            }\n        ],\n        \"monitoring\": [\n            \"Serum creatinine and BUN\",\n            \"Urine protein-to-creatinine ratio\",\n            \"Complete blood count (CBC)\",\n            \"Complement levels (C3, C4)\",\n            \"ANA and anti-dsDNA titers\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Nephrology\",\n                \"urgency\": \"Urgent\",\n                \"reason\": \"For management of lupus nephritis and renal function monitoring\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Significant proteinuria\",\n        \"Decreased eGFR\",\n        \"Worsening renal function\",\n        \"Development of hypertension\"\n    ],\n    \"patient_education\": [\n        \"Explain the diagnosis of SLE and the importance of long-term management\",\n        \"Educate on potential side effects of corticosteroids\",\n        \"Advise on lifestyle modifications (e.g., low-sodium diet, regular exercise)\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"Within 24-48 hours for initial assessment and initiation of treatment, then weekly for monitoring\",\n        \"conditions\": \"Return sooner if symptoms worsen, renal function declines, or new symptoms develop\"\n    },\n    \"confidence_in_assessment\": 0.85,\n    \"uncertainties\": [\n        \"The absence of renal stones on CT scan does not exclude IgA nephropathy.\",\n        \"The exact stage and severity of lupus nephritis are currently unknown and require renal biopsy.\"\n    ]\n}\n```",
      "response_time": 1.0,
      "cached": true,
      "case_id": "Case_13",
      "timestamp": "2025-08-11T21:23:05.184775",
      "tokens_used": 1303,
      "input_tokens": 0,
      "output_tokens": 0
    },
    {
      "model_name": "openai/gpt-4o",
      "response": "```json\n{\n    \"primary_diagnosis\": {\n        \"name\": \"IgA Nephropathy (Berger's Disease)\",\n        \"confidence\": 0.8,\n        \"icd_code\": \"N02.8\",\n        \"reasoning\": \"The patient's symptoms, including recurrent episodes of hematuria, proteinuria, and dysmorphic RBCs with RBC casts, along with low complement levels, suggest a glomerulonephritis. IgA nephropathy is common in this demographic and fits the clinical presentation.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Lupus Nephritis\",\n            \"confidence\": 0.6,\n            \"icd_code\": \"M32.14\",\n            \"reasoning\": \"Positive ANA and low complement levels are consistent with lupus nephritis. However, the absence of other systemic lupus erythematosus symptoms lowers confidence.\"\n        },\n        {\n            \"name\": \"Alport Syndrome\",\n            \"confidence\": 0.5,\n            \"icd_code\": \"Q87.81\",\n            \"reasoning\": \"Family history of kidney problems and hematuria could suggest a hereditary nephritis such as Alport syndrome, especially in young males.\"\n        },\n        {\n            \"name\": \"Membranoproliferative Glomerulonephritis\",\n            \"confidence\": 0.4,\n            \"icd_code\": \"N14.0\",\n            \"reasoning\": \"The presentation could also fit membranoproliferative glomerulonephritis, especially with low complement levels, but lacks definitive systemic features.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Intermittent gross hematuria and dysuria\",\n        \"Low C3 and C4 complement levels\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Renal Biopsy\",\n            \"purpose\": \"To confirm glomerulonephritis type\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Anti-dsDNA\",\n            \"purpose\": \"To assess for lupus nephritis\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"ANCA panel\",\n            \"purpose\": \"To rule out ANCA-associated vasculitis\",\n            \"priority\": \"routine\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Monitor renal function and electrolytes\",\n            \"Control blood pressure aggressively\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Lisinopril\",\n                \"dose\": \"10 mg\",\n                \"route\": \"PO\",\n                \"duration\": \"Daily\",\n                \"rationale\": \"ACE inhibitor to reduce proteinuria and control blood pressure\"\n            },\n            {\n                \"drug\": \"Prednisone\",\n                \"dose\": \"40 mg\",\n                \"route\": \"PO\",\n                \"duration\": \"Daily for 4 weeks, then taper\",\n                \"rationale\": \"To reduce inflammation if renal biopsy suggests IgA nephropathy or lupus nephritis\"\n            }\n        ],\n        \"monitoring\": [\n            \"Serum creatinine and eGFR\",\n            \"Weekly\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Nephrology\",\n                \"urgency\": \"immediate\",\n                \"reason\": \"For further evaluation and management of suspected glomerulonephritis\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Rapid decrease in urine output\",\n        \"Severe hypertension\"\n    ],\n    \"patient_education\": [\n        \"Importance of medication adherence\",\n        \"Signs of worsening kidney function\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"2 weeks\",\n        \"conditions\": \"Increased swelling, decreased urine output, or severe symptoms\"\n    },\n    \"confidence_in_assessment\": 0.8,\n    \"uncertainties\": [\n        \"Exact type of glomerulonephritis without biopsy\",\n        \"Potential overlap with autoimmune conditions\"\n    ]\n}\n```",
      "response_time": 20.32145380973816,
      "cached": true,
      "case_id": "Case_13",
      "timestamp": "2025-08-11T21:24:28.888724",
      "tokens_used": 2291,
      "input_tokens": 1445,
      "output_tokens": 846
    },
    {
      "model_name": "google/gemini-2.5-flash",
      "response": "```json\n{\n    \"primary_diagnosis\": {\n        \"name\": \"IgA Nephropathy (Berger's Disease)\",\n        \"confidence\": 0.85,\n        \"icd_code\": \"N02.8\",\n        \"reasoning\": \"Recurrent gross hematuria, dysmorphic RBCs, RBC casts, granular casts, proteinuria (3+), hypertension, acute kidney injury (elevated Cr, BUN, decreased GFR), and flank pain are highly suggestive of glomerulonephritis. The intermittent nature, young male, and ethnicity (more common in Asians/Middle Easterners) fit IgA nephropathy. The low C3/C4 are less typical for classic IgA, but can be seen in variants or co-existing conditions, or could be a lab error/artifact if not re-checked. The recurrent 'kidney stones' history might be misdiagnosed prior episodes of macroscopic hematuria.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Post-streptococcal Glomerulonephritis (PSGN)\",\n            \"confidence\": 0.55,\n            \"icd_code\": \"N03.0\",\n            \"reasoning\": \"Presents with hematuria, proteinuria, AKI, edema, hypertension. However, the 6-month intermittent course is less typical for PSGN, which usually follows a distinct infection and resolves or progresses. Lack of recent strep infection or sore throat also argues against it. The low C3/C4 could be seen in PSGN, but the chronicity makes it less likely as a primary diagnosis.\"\n        },\n        {\n            \"name\": \"Membranoproliferative Glomerulonephritis (MPGN) / C3 Glomerulopathy\",\n            \"confidence\": 0.5,\n            \"icd_code\": \"N07.8\",\n            \"reasoning\": \"Can present with hematuria, proteinuria, AKI, hypertension, and often has low C3 (and sometimes C4). The chronicity and intermittent nature could fit. Renal biopsy would be crucial to differentiate from IgA nephropathy or other causes of glomerulonephritis.\"\n        },\n        {\n            \"name\": \"Systemic Lupus Erythematosus (SLE) with Lupus Nephritis\",\n            \"confidence\": 0.45,\n            \"icd_code\": \"M32.14\",\n            \"reasoning\": \"Positive ANA, proteinuria, hematuria, AKI, hypertension, and fatigue are consistent with SLE. The low C3/C4 are also highly suggestive of SLE. The pending anti-dsDNA is critical. The intermittent nature of symptoms is less typical but possible for lupus flares. Environmental exposure to chemicals could be a trigger for autoimmune diseases.\"\n        },\n        {\n            \"name\": \"Alport Syndrome (hereditary nephritis)\",\n            \"confidence\": 0.3,\n            \"icd_code\": \"Q87.81\",\n            \"reasoning\": \"Family history of 'kidney problems,' recurrent hematuria, and progressive renal impairment are classic features. However, it often presents earlier in childhood and can be associated with hearing loss or ocular abnormalities, which are not mentioned. Renal biopsy and genetic testing would confirm.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Recurrent gross hematuria with dysmorphic RBCs and RBC casts\",\n        \"Acute kidney injury (Cr 2.1, BUN 45, eGFR 42)\",\n        \"Nephrotic range proteinuria (3+)\",\n        \"Hypertension (BP 145/92) with periorbital and peripheral edema\",\n        \"Low C3 and C4 complement levels\",\n        \"Positive ANA (1:160 homogeneous)\",\n        \"Bilateral renal enlargement and increased echogenicity on imaging\",\n        \"Family history of 'kidney problems'\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Kidney Biopsy\",\n            \"purpose\": \"Definitive diagnosis of specific glomerulonephritis type (e.g., IgA nephropathy, lupus nephritis, MPGN), assessment of chronicity and activity.\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Anti-dsDNA antibody\",\n            \"purpose\": \"To confirm or rule out Systemic Lupus Erythematosus as a cause of glomerulonephritis given positive ANA and low complements.\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Repeat Serum C3 and C4 levels\",\n            \"purpose\": \"To confirm initial low values and rule out laboratory error, guiding further autoimmune workup.\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"24-hour urine protein collection\",\n            \"purpose\": \"Quantify proteinuria to assess severity and response to treatment.\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Serum Electrophoresis with Immunofixation\",\n            \"purpose\": \"To rule out monoclonal gammopathy of renal significance (MGRS) which can cause various types of glomerulonephritis and AKI.\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Hepatitis B & C, HIV serologies\",\n            \"purpose\": \"To rule out viral-associated glomerulonephritis.\",\n            \"priority\": \"routine\"\n        },\n        {\n            \"test\": \"Genetic testing for Alport Syndrome\",\n            \"purpose\": \"Consider if biopsy is inconclusive or highly suggestive of hereditary nephritis given family history.\",\n            \"priority\": \"routine\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Hospital admission for close monitoring of renal function, blood pressure, and fluid status.\",\n            \"Initiate strict fluid intake monitoring and daily weights.\",\n            \"Start blood pressure management.\",\n            \"Consult Nephrology immediately.\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Lisinopril (or other ACE inhibitor/ARB)\",\n                \"dose\": \"2.5-5 mg daily, titrate to BP and renal function\",\n                \"route\": \"PO\",\n                \"duration\": \"Long-term\",\n                \"rationale\": \"To control hypertension and reduce proteinuria (renoprotective effect).\"\n            },\n            {\n                \"drug\": \"Furosemide\",\n                \"dose\": \"20-40 mg daily, titrate to edema/fluid status\",\n                \"route\": \"PO\",\n                \"duration\": \"As needed for fluid overload\",\n                \"rationale\": \"To manage fluid overload and edema.\"\n            },\n            {\n                \"drug\": \"Methylprednisolone (IV)\",\n                \"dose\": \"250-500 mg daily for 3 days, then oral prednisone\",\n                \"route\": \"IV\",\n                \"duration\": \"Short course for severe AKI/glomerulonephritis flare\",\n                \"rationale\": \"Empiric immunosuppression for rapidly progressive glomerulonephritis while awaiting biopsy results, especially if lupus nephritis or severe IgA nephropathy is suspected.\"\n            }\n        ],\n        \"monitoring\": [\n            \"Daily vital signs (BP, HR, Temp, RR) and fluid balance (intake/output).\",\n            \"Daily weights.\",\n            \"Serum creatinine, BUN, electrolytes daily initially, then every 1-2 days until stable.\",\n            \"Urinalysis weekly until stable.\",\n            \"Blood pressure at home once discharged.\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Nephrology\",\n                \"urgency\": \"immediate\",\n                \"reason\": \"Expert management of acute kidney injury, glomerulonephritis workup (including biopsy), and long-term renal care.\"\n            },\n            {\n                \"specialty\": \"Rheumatology\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"If anti-dsDNA is positive or SLE is highly suspected, for co-management of systemic autoimmune disease.\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Acute kidney injury with rapidly declining GFR\",\n        \"Significant proteinuria and hematuria with casts (active glomerular inflammation)\",\n        \"Uncontrolled hypertension\",\n        \"Fluid overload/edema\",\n        \"Low C3 and C4 complement levels (suggestive of complement consumption)\",\n        \"Potential for rapidly progressive glomerulonephritis\"\n    ],\n    \"patient_education\": [\n        \"Explanation of suspected kidney disease (glomerulonephritis) and its potential severity.\",\n        \"Importance of kidney biopsy for definitive diagnosis and guiding treatment.\",\n        \"Strict adherence to medication regimen (blood pressure control, immunosuppression if prescribed).\",\n        \"Dietary modifications: low sodium, low potassium, fluid restriction as advised.\",\n        \"Symptoms requiring immediate medical attention (e.g., severe headache, vision changes, increased swelling, decreased urine output, fever).\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"Daily in hospital initially, then weekly with Nephrology after discharge, then",
      "response_time": 13.158420324325562,
      "cached": true,
      "case_id": "Case_13",
      "timestamp": "2025-08-11T21:26:03.177643",
      "tokens_used": 3561,
      "input_tokens": 1554,
      "output_tokens": 2007
    },
    {
      "model_name": "meta-llama/llama-3.2-3b-instruct",
      "response": "{\n  \"primary_diagnosis\": {\n    \"name\": \"IgA Nephropathy with Hematuria\",\n    \"confidence\": 0.8,\n    \"icd_code\": \"Nephritis, IgA with Hematuria (N0180)\",\n    \"reasoning\": \"Presence of IgA nephropathy is suggested by the clinical presentation of recurrent hematuria, particularly in a young male patient with a Middle Eastern heritage. The patient's recurrent episodes of dysuria, gross hematuria, and suprapubic discomfort, along with the presence of dysmorphic RBCs and granular casts, support this diagnosis\"\n  },\n  \"differential_diagnoses\": [\n    {\n      \"name\": \"Interstitial Nephritis\",\n      \"confidence\": 0.4,\n      \"icd_code\": \"Nephritis, Immune-Mediated (M32)\",\n      \"reasoning\": \"The patient's symptoms of hematuria, dysuria, and flank pain, along with the presence of leukocytosis and elevated ESR, suggest interstitial nephritis as a possible alternative diagnosis\"\n    },\n    {\n      \"name\": \"Pyelonephritis\",\n      \"confidence\": 0.3,\n      \"icd_code\": \"Nephritis, Acute Bacterial (A04)\",\n      \"reasoning\": \"The patient's symptoms of fever, leukocytosis, and elevated WBC count, although not present, and the presence of abnormal urinalysis findings, suggest pyelonephritis as a possible alternative diagnosis\"\n    },\n    {\n      \"name\": \"Chronic Kidney Disease\",\n      \"confidence\": 0.2,\n      \"icd_code\": \"Nephritis, Chronic (M32)\",\n      \"reasoning\": \"The patient's elevated creatinine and eGFR, along with the presence of proteinuria, suggest chronic kidney disease as a possible alternative diagnosis\"\n    }\n  ],\n  \"key_findings\": [\n    \"Proteinuria (3+ protein on urinalysis)\",\n    \"Bilateral flank pain and decreased urine output\"\n  ],\n  \"diagnostic_tests\": [\n    {\n      \"test\": \"Immunofluorescence study on urine\",\n      \"purpose\": \"To confirm the presence of IgA deposits\",\n      \"priority\": \"immediate\"\n    },\n    {\n      \"test\": \"Kidney biopsy\",\n      \"purpose\": \"To confirm the diagnosis and rule out other causes\",\n      \"priority\": \"routine\"\n    }\n  ],\n  \"management_plan\": {\n    \"immediate_actions\": [\n      \"Initiate immunosuppressive therapy (e.g., prednisone 40mg PO bid) to reduce inflammation and prevent further kidney damage\",\n      \"Monitor urine proteinuria and creatinine levels closely\"\n    ],\n    \"medications\": [\n      {\n        \"drug\": \"Prednisone\",\n        \"dose\": \"40mg PO bid\",\n        \"route\": \"PO\",\n        \"duration\": \"Indefinite\",\n        \"rationale\": \"To reduce inflammation and prevent further kidney damage\"\n      }\n    ],\n    \"monitoring\": [\n      \"Regular urinalysis and serum creatinine levels\",\n      \"Monthly kidney function tests\"\n    ],\n    \"consultations\": [\n      {\n        \"specialty\": \"Nephrology\",\n        \"urgency\": \"immediate\",\n        \"reason\": \"To closely monitor kidney function and adjust treatment as needed\"\n      }\n    ]\n  },\n  \"red_flags\": [\n    \"Severe proteinuria (>3+)\",\n    \"Elevated serum creatinine\"\n  ],\n  \"patient_education\": [\n    \"The patient should be educated about the importance of strict blood sugar control, as IgA nephropathy is associated with diabetes mellitus\",\n    \"The patient should avoid strenuous physical activity and maintain a healthy diet to reduce the risk of further kidney damage\"\n  ],\n  \"follow_up\": {\n    \"timing\": \"Every 3 months\",\n    \"conditions\": \"Kidney function tests and urinalysis\"\n  },\n  \"confidence_in_assessment\": 0.8,\n  \"uncertainties\": [\n    \"The exact cause of the patient's symptoms remains uncertain\",\n    \"The patient's family medical history may provide additional information about the underlying cause of IgA nephropathy\"\n  ]\n}",
      "response_time": 4.7755022048950195,
      "cached": true,
      "case_id": "Case_13",
      "timestamp": "2025-08-11T21:26:17.143812",
      "tokens_used": 2369,
      "input_tokens": 1467,
      "output_tokens": 902
    },
    {
      "model_name": "openai/gpt-4o-mini",
      "response": "{\n    \"primary_diagnosis\": {\n        \"name\": \"IgA Nephropathy\",\n        \"confidence\": 0.85,\n        \"icd_code\": \"N04.9\",\n        \"reasoning\": \"Patient presents with hematuria, proteinuria, and renal dysfunction, consistent with IgA nephropathy, especially given the family history of kidney issues.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Lupus Nephritis\",\n            \"confidence\": 0.75,\n            \"icd_code\": \"M32.1\",\n            \"reasoning\": \"Positive ANA and low complement levels suggest possible autoimmune process affecting the kidneys.\"\n        },\n        {\n            \"name\": \"Chronic Kidney Disease (CKD)\",\n            \"confidence\": 0.70,\n            \"icd_code\": \"N18.9\",\n            \"reasoning\": \"Elevated creatinine and BUN levels indicate possible chronic kidney disease, potentially secondary to recurrent kidney stones or underlying nephritis.\"\n        },\n        {\n            \"name\": \"Renal Cell Carcinoma\",\n            \"confidence\": 0.50,\n            \"icd_code\": \"C64.9\",\n            \"reasoning\": \"Gross hematuria and flank pain raise suspicion; less likely given imaging results but still a consideration.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Intermittent gross hematuria and dysuria\",\n        \"Bilateral renal enlargement and elevated creatinine\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Anti-dsDNA Antibodies\",\n            \"purpose\": \"To rule in/out lupus nephritis\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Kidney Biopsy\",\n            \"purpose\": \"To confirm diagnosis of IgA nephropathy or other glomerular disease\",\n            \"priority\": \"urgent\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Initiate hydration and monitor renal function closely\",\n            \"Refer to nephrology for specialized care\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Prednisone\",\n                \"dose\": \"0.5-1 mg/kg/day\",\n                \"route\": \"PO\",\n                \"duration\": \"6-12 weeks\",\n                \"rationale\": \"To reduce inflammation and proteinuria in suspected IgA nephropathy.\"\n            }\n        ],\n        \"monitoring\": [\n            \"Renal function tests (creatinine, BUN)\",\n            \"Every 1-2 weeks during treatment\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Nephrology\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"Need for specialized evaluation and management of renal condition.\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Rapidly worsening renal function\",\n        \"Severe persistent flank pain\"\n    ],\n    \"patient_education\": [\n        \"Importance of follow-up appointments for kidney health\",\n        \"Signs of worsening condition to watch for, such as increasing edema or decreased urine output\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"2 weeks after initial management\",\n        \"conditions\": \"Any significant change in symptoms or renal function\"\n    },\n    \"confidence_in_assessment\": 0.80,\n    \"uncertainties\": [\n        \"Exact cause of hematuria and proteinuria\",\n        \"Potential autoimmune etiology requiring further investigation\"\n    ]\n}",
      "response_time": 15.938045024871826,
      "cached": true,
      "case_id": "Case_13",
      "timestamp": "2025-08-11T21:24:44.828287",
      "tokens_used": 2176,
      "input_tokens": 1445,
      "output_tokens": 731
    },
    {
      "model_name": "qwen/qwen-2.5-coder-32b-instruct",
      "response": "{\n    \"primary_diagnosis\": {\n        \"name\": \"Systemic Lupus Erythematosus (SLE) with Nephritis\",\n        \"confidence\": 0.85,\n        \"icd_code\": \"M32.9\",\n        \"reasoning\": \"Positive ANA, low C3/C4, proteinuria, hematuria, and acute kidney injury are indicative of SLE nephritis. Family history of kidney problems and the recent development of systemic symptoms (bilateral flank pain, decreased urine output, weight gain) further support this diagnosis.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Chronic Pyelonephritis\",\n            \"confidence\": 0.15,\n            \"icd_code\": \"N13.9\",\n            \"reasoning\": \"Recurrent episodes of dysuria and hematuria, along with the development of new symptoms such as flank pain and decreased urine output, could suggest chronic pyelonephritis. However, the absence of fever and the lack of a specific infecting organism in the urine culture make this less likely.\"\n        },\n        {\n            \"name\": \"IgA Nephropathy\",\n            \"confidence\": 0.05,\n            \"icd_code\": \"N08.1\",\n            \"reasoning\": \"IgA nephropathy can present with hematuria and proteinuria, but the absence of significant gastrointestinal symptoms and the presence of ANA suggest this is less likely.\"\n        },\n        {\n            \"name\": \"Renal Cell Carcinoma\",\n            \"confidence\": 0.05,\n            \"icd_code\": \"C64.9\",\n            \"reasoning\": \"Bilateral renal enlargement on imaging can be seen in renal cell carcinoma. However, the absence of symptoms such as flank mass, persistent pain, and weight loss makes this less likely.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Positive ANA with homogeneous pattern\",\n        \"Low levels of C3 and C4\",\n        \"Acute kidney injury with elevated creatinine and BUN\",\n        \"Proteinuria and hematuria on urinalysis\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Anti-dsDNA and ANCA\",\n            \"purpose\": \"To confirm SLE diagnosis\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Renal Biopsy\",\n            \"purpose\": \"To confirm diagnosis and assess extent of renal involvement\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"24-Hour Urine Protein\",\n            \"purpose\": \"To quantify proteinuria\",\n            \"priority\": \"routine\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Initiate corticosteroids for SLE\",\n            \"Hydrate patient to improve kidney function\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Prednisone\",\n                \"dose\": \"1 mg/kg/day\",\n                \"route\": \"PO\",\n                \"duration\": \"Indefinite, taper as needed\",\n                \"rationale\": \"High-dose corticosteroids are standard treatment for SLE nephritis\"\n            },\n            {\n                \"drug\": \"Mycophenolate Mofetil\",\n                \"dose\": \"1g twice daily\",\n                \"route\": \"PO\",\n                \"duration\": \"Indefinite\",\n                \"rationale\": \"Add-on immunosuppressant for severe lupus nephritis\"\n            }\n        ],\n        \"monitoring\": [\n            \"Blood pressure\",\n            \"Urinalysis\",\n            \"Renal function tests (BUN, creatinine, eGFR)\",\n            \"Complete Blood Count (CBC)\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Rheumatology\",\n                \"urgency\": \"immediate\",\n                \"reason\": \"For diagnosis and management of SLE\"\n            },\n            {\n                \"specialty\": \"Nephrology\",\n                \"urgency\": \"immediate\",\n                \"reason\": \"For management of lupus nephritis and acute kidney injury\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Persistent fever\",\n        \"Severe pain or worsening renal function\",\n        \"Development of pulmonary symptoms\"\n    ],\n    \"patient_education\": [\n        \"Importance of adherence to medication regimen\",\n        \"Awareness of signs of disease flare-up\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"In 2-4 weeks or sooner if symptoms worsen\",\n        \"conditions\": \"Immediate return if fever, severe pain, or signs of infection\"\n    },\n    \"confidence_in_assessment\": 0.85,\n    \"uncertainties\": [\n        \"Pending ANCA and Anti-dsDNA results\",\n        \"Baseline renal function unknown, making acute kidney injury assessment challenging\"\n    ]\n}",
      "response_time": 24.305794954299927,
      "cached": true,
      "case_id": "Case_13",
      "timestamp": "2025-08-11T21:27:54.929716",
      "tokens_used": 2548,
      "input_tokens": 1511,
      "output_tokens": 1037
    },
    {
      "model_name": "anthropic/claude-3.7-sonnet",
      "response": "{\n    \"primary_diagnosis\": {\n        \"name\": \"IgA Nephropathy\",\n        \"confidence\": 0.8,\n        \"icd_code\": \"N02.8\",\n        \"reasoning\": \"The patient presents with classic features of IgA nephropathy including recurrent gross hematuria with concurrent upper respiratory infections, dysmorphic RBCs, RBC casts, proteinuria, and declining renal function. The presence of bilateral flank pain, edema, and hypertension suggests active glomerulonephritis. Low complement levels (C3, C4), positive ANA, and family history of kidney disease further support an immune-mediated glomerular disease. The episodic nature with complete resolution between episodes is characteristic of IgA nephropathy.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Lupus Nephritis\",\n            \"confidence\": 0.6,\n            \"icd_code\": \"M32.14\",\n            \"reasoning\": \"Positive ANA, hypocomplementemia, proteinuria, hematuria, and renal dysfunction suggest possible lupus nephritis. The pending anti-dsDNA could further support this diagnosis. However, the patient lacks other systemic manifestations of SLE.\"\n        },\n        {\n            \"name\": \"ANCA-Associated Vasculitis\",\n            \"confidence\": 0.5,\n            \"icd_code\": \"M31.30\",\n            \"reasoning\": \"Hematuria, proteinuria, and renal dysfunction could represent renal involvement in ANCA-associated vasculitis. Pending ANCA results will help clarify. The episodic nature and lack of systemic symptoms make this less likely.\"\n        },\n        {\n            \"name\": \"Thin Basement Membrane Disease\",\n            \"confidence\": 0.4,\n            \"icd_code\": \"N02.2\",\n            \"reasoning\": \"Given the patient's age, family history of kidney disease, and persistent hematuria, thin basement membrane disease is possible. However, the significant proteinuria, RBC casts, and declining renal function are atypical.\"\n        },\n        {\n            \"name\": \"Occupational Nephropathy\",\n            \"confidence\": 0.3,\n            \"icd_code\": \"N14.4\",\n            \"reasoning\": \"The patient's work in chemistry with exposure to various solvents raises concern for chemical-induced nephropathy. The temporal relationship between work exposure and symptoms would need further exploration.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Recurrent gross hematuria and dysuria for 6 months\",\n        \"Dysmorphic RBCs and RBC casts in urine\",\n        \"Significant proteinuria (3+)\",\n        \"Elevated creatinine (2.1 mg/dL) with reduced eGFR (42 mL/min)\",\n        \"Hypertension (145/92 mmHg)\",\n        \"Peripheral and periorbital edema\",\n        \"Low complement levels (C3 and C4)\",\n        \"Positive ANA (1:160)\",\n        \"Bilateral renal enlargement on imaging\",\n        \"Family history of kidney disease\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Renal Biopsy\",\n            \"purpose\": \"Definitive diagnosis of glomerular pathology and assessment of disease activity and chronicity\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"24-hour Urine Protein and Creatinine\",\n            \"purpose\": \"Quantify proteinuria and assess renal function\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Anti-dsDNA, Anti-Smith, Anti-SSA/SSB Antibodies\",\n            \"purpose\": \"Evaluate for lupus nephritis\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"ANCA (MPO and PR3)\",\n            \"purpose\": \"Evaluate for ANCA-associated vasculitis\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Anti-GBM Antibodies\",\n            \"purpose\": \"Rule out Goodpasture's syndrome\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Serum and Urine Protein Electrophoresis\",\n            \"purpose\": \"Rule out paraproteinemia\",\n            \"priority\": \"routine\"\n        },\n        {\n            \"test\": \"Hepatitis B, C, and HIV Serology\",\n            \"purpose\": \"Rule out infectious causes of glomerulonephritis\",\n            \"priority\": \"routine\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Admit to hospital for expedited workup and management of acute kidney injury\",\n            \"Fluid restriction to 1.5-2L/day given edema and hypertension\",\n            \"Sodium restriction (<2g/day)\",\n            \"Daily weights and strict intake/output monitoring\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Amlodipine\",\n                \"dose\": \"5-10mg\",\n                \"route\": \"oral\",\n                \"duration\": \"As needed for BP control\",\n                \"rationale\": \"Control hypertension to target <130/80 mmHg to slow progression of kidney disease\"\n            },\n            {\n                \"drug\": \"Furosemide\",\n                \"dose\": \"20-40mg\",\n                \"route\": \"oral\",\n                \"duration\": \"As needed for edema\",\n                \"rationale\": \"Manage volume overload and edema\"\n            },\n            {\n                \"drug\": \"Methylprednisolone\",\n                \"dose\": \"Pending biopsy results\",\n                \"route\": \"IV/oral\",\n                \"duration\": \"To be determined based on biopsy\",\n                \"rationale\": \"Immunosuppression for presumed immune-mediated glomerulonephritis\"\n            }\n        ],\n        \"monitoring\": [\n            \"Daily basic metabolic panel\",\n            \"Daily urine output\",\n            \"Daily weights\",\n            \"Blood pressure monitoring every 4 hours\",\n            \"Fluid balance\",\n            \"Urinalysis for hematuria and proteinuria\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Nephrology\",\n                \"urgency\": \"immediate\",\n                \"reason\": \"Management of acute kidney injury and suspected glomerulonephritis\"\n            },\n            {\n                \"specialty\": \"Rheumatology\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"Evaluation of possible systemic autoimmune disease\"\n            },\n            {\n                \"specialty\": \"Occupational Medicine\",\n                \"urgency\": \"routine\",\n                \"reason\": \"Assessment of potential chemical exposures in chemistry laboratory\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Rapidly declining renal function (eGFR 42 mL/min)\",\n        \"Significant proteinuria with hypoalbuminemia and edema suggesting nephrotic syndrome\",\n        \"Hypertension requiring prompt control\",\n        \"Low complement levels suggesting active immune-mediated process\",\n        \"Occupational exposure to potentially nephrotoxic chemicals\"\n    ],\n    \"patient_education\": [\n        \"Explanation of glomerulonephritis and potential causes\",\n        \"Importance of medication adherence and follow-up\",\n        \"Dietary sodium and protein restrictions\",\n        \"Self-monitoring for edema, weight changes, and urine appearance\",\n        \"Potential need for long-term immunosuppressive therapy\",\n        \"Occupational safety measures if chemical exposure is confirmed as contributory\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"Weekly nephrology follow-up after discharge until stabilized, then monthly\",\n        \"conditions\": \"Return immediately for worsening edema, decreased urine output, shortness of breath, or severe headache\"\n    },\n    \"confidence_in_assessment\": 0.8,\n    \"uncertainties\": [\n        \"Definitive diagnosis requires renal biopsy\",\n        \"Contribution of occupational exposures to kidney disease\",\n        \"Long-term prognosis and risk of progression to end-stage renal disease\",\n        \"Potential need for immunosuppressive therapy beyond steroids",
      "response_time": 1.0,
      "cached": true,
      "case_id": "Case_13",
      "timestamp": "2025-08-11T22:00:59.007796",
      "tokens_used": 3410,
      "input_tokens": 0,
      "output_tokens": 0
    },
    {
      "model_name": "anthropic/claude-3-opus-20240229",
      "response": "{\n    \"primary_diagnosis\": {\n        \"name\": \"Lupus nephritis\",\n        \"confidence\": 0.8,\n        \"icd_code\": \"M32.14\",\n        \"reasoning\": \"Recurrent episodes of hematuria, proteinuria, and RBC casts suggesting glomerulonephritis. Positive ANA, low complements, and dysmorphic RBCs support lupus nephritis.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"IgA nephropathy\",\n            \"confidence\": 0.6,\n            \"icd_code\": \"N02.8\",\n            \"reasoning\": \"Recurrent gross hematuria and flank pain can occur with IgA nephropathy. Family history of kidney problems also raises suspicion.\"\n        },\n        {\n            \"name\": \"Membranoproliferative glomerulonephritis (MPGN)\",\n            \"confidence\": 0.5,\n            \"icd_code\": \"N05.5\",\n            \"reasoning\": \"Presents similarly to lupus nephritis with hematuria, proteinuria, and low complements. Can be idiopathic or secondary to chronic infections or autoimmune diseases.\"\n        },\n        {\n            \"name\": \"Chronic pyelonephritis\",\n            \"confidence\": 0.3,\n            \"icd_code\": \"N11.9\",\n            \"reasoning\": \"Recurrent UTI symptoms with temporary response to antibiotics. However, negative urine cultures and presence of RBC casts make this less likely.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Recurrent episodes of gross hematuria, proteinuria, and RBC casts\",\n        \"Positive ANA, low complements (C3, C4)\",\n        \"Acute kidney injury with elevated creatinine and edema\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Anti-dsDNA antibodies\",\n            \"purpose\": \"Confirm diagnosis of lupus nephritis if positive\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Kidney biopsy\",\n            \"purpose\": \"Definitive diagnosis and determine class of lupus nephritis\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"24-hour urine protein and creatinine clearance\",\n            \"purpose\": \"Quantify proteinuria and assess kidney function\",\n            \"priority\": \"urgent\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Admit to hospital for expedited workup and management\",\n            \"Start IV methylprednisolone 500-1000 mg daily for 3 days\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Mycophenolate mofetil\",\n                \"dose\": \"1000-1500 mg PO BID\",\n                \"route\": \"PO\",\n                \"duration\": \"Induction therapy x 6 months\",\n                \"rationale\": \"Immunosuppression for lupus nephritis\"\n            },\n            {\n                \"drug\": \"Prednisone\",\n                \"dose\": \"1 mg/kg/day PO\",\n                \"route\": \"PO\",\n                \"duration\": \"Taper over 3-6 months\",\n                \"rationale\": \"Corticosteroid for inflammation\"\n            }\n        ],\n        \"monitoring\": [\n            \"Daily weights, I/Os, renal function, BP\",\n            \"Repeat UA, urine protein/creatinine ratio monthly\"   \n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Nephrology\",\n                \"urgency\": \"immediate\",\n                \"reason\": \"Suspected lupus nephritis, may need biopsy\"\n            },\n            {\n                \"specialty\": \"Rheumatology\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"Manage underlying SLE\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Rapidly progressive glomerulonephritis\",\n        \"Pulmonary hemorrhage (rare but life-threatening complication of lupus)\"\n    ],\n    \"patient_education\": [\n        \"Lupus is a chronic autoimmune disease that can affect multiple organ systems\",\n        \"Compliance with immunosuppressive medications is critical to preserve kidney function\",\n        \"Regular rheumatology and nephrology follow-up will be needed\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"Within 1 week of hospital discharge\",\n        \"conditions\": \"Worsening edema, oliguria, shortness of breath, hemoptysis\"\n    },\n    \"confidence_in_assessment\": 0.8,\n    \"uncertainties\": [\n        \"Biopsy results pending to confirm class of lupus nephritis\",\n        \"Unclear baseline kidney function prior to this episode\"\n    ]\n}",
      "response_time": 38.76352405548096,
      "cached": true,
      "case_id": "Case_13",
      "timestamp": "2025-08-11T21:25:27.742831",
      "tokens_used": 2878,
      "input_tokens": 1694,
      "output_tokens": 1184
    },
    {
      "model_name": "qwen/qwen-2.5-72b-instruct/free",
      "response": "{\n    \"primary_diagnosis\": {\n        \"name\": \"Lupus Nephritis\",\n        \"confidence\": 0.85,\n        \"icd_code\": \"M32.1\",\n        \"reasoning\": \"The patient presents with a 6-month history of intermittent dysuria, gross hematuria, and suprapubic discomfort, which has recently progressed to bilateral flank pain, decreased urine output, and weight gain. Laboratory findings show proteinuria, hematuria with dysmorphic RBCs and RBC casts, low complement levels (C3 and C4), and a positive ANA. These findings are highly suggestive of lupus nephritis, particularly given the patient's family history of kidney problems and the presence of systemic symptoms such as fatigue and edema.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"IgA Nephropathy\",\n            \"confidence\": 0.6,\n            \"icd_code\": \"N02.0\",\n            \"reasoning\": \"The presence of dysmorphic RBCs and RBC casts in the urine, along with proteinuria, could also suggest IgA nephropathy. However, the low complement levels and positive ANA are less consistent with this diagnosis.\"\n        },\n        {\n            \"name\": \"Acute Interstitial Nephritis\",\n            \"confidence\": 0.4,\n            \"icd_code\": \"N10\",\n            \"reasoning\": \"The patient's history of recurrent antibiotic use and the presence of leukocyturia could suggest acute interstitial nephritis. However, the low complement levels and positive ANA are more indicative of an autoimmune process.\"\n        },\n        {\n            \"name\": \"Post-infectious Glomerulonephritis\",\n            \"confidence\": 0.3,\n            \"icd_code\": \"N00.9\",\n            \"reasoning\": \"The patient's history of recurrent urinary symptoms and the presence of hematuria and proteinuria could suggest post-infectious glomerulonephritis. However, the absence of a recent infection and the low complement levels are less consistent with this diagnosis.\"\n        }\n    ],\n    \"key_findings\": [\"Dysmorphic RBCs and RBC casts in urine\", \"Low complement levels (C3 and C4)\", \"Positive ANA\", \"Bilateral renal enlargement on imaging\", \"Proteinuria and hematuria\"],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Anti-dsDNA\",\n            \"purpose\": \"To confirm the presence of systemic lupus erythematosus (SLE)\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"ANCA\",\n            \"purpose\": \"To rule out vasculitis\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"24-hour urine\",\n            \"purpose\": \"To quantify proteinuria and assess renal function\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Renal biopsy\",\n            \"purpose\": \"To confirm the diagnosis of lupus nephritis and determine the class and severity\",\n            \"priority\": \"urgent\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\"Start IV fluids for volume expansion\", \"Monitor electrolytes and renal function\"],\n        \"medications\": [\n            {\n                \"drug\": \"Prednisone\",\n                \"dose\": \"1 mg/kg/day\",\n                \"route\": \"oral\",\n                \"duration\": \"4-6 weeks, then taper\",\n                \"rationale\": \"To reduce inflammation and control the immune response in lupus nephritis\"\n            },\n            {\n                \"drug\": \"Hydroxychloroquine\",\n                \"dose\": \"200 mg twice daily\",\n                \"route\": \"oral\",\n                \"duration\": \"long-term\",\n                \"rationale\": \"To control systemic lupus erythematosus and prevent flares\"\n            }\n        ],\n        \"monitoring\": [\"Creatinine and BUN\", \"Electrolytes\", \"Urine protein-to-creatinine ratio\", \"Complement levels (C3 and C4)\"],\n        \"consultations\": [\n            {\n                \"specialty\": \"Nephrology\",\n                \"urgency\": \"immediate\",\n                \"reason\": \"For management of lupus nephritis and consideration of renal biopsy\"\n            },\n            {\n                \"specialty\": \"Rheumatology\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"For management of systemic lupus erythematosus\"\n            }\n        ]\n    },\n    \"red_flags\": [\"Rapidly declining renal function\", \"Severe hypertension\", \"Significant proteinuria\", \"Acute kidney injury\"],\n    \"patient_education\": [\"Importance of adherence to prescribed medications\", \"Signs and symptoms of worsening renal function\", \"Importance of regular follow-up appointments\"],\n    \"follow_up\": {\n        \"timing\": \"1 week\",\n        \"conditions\": \"Worsening symptoms, significant weight gain, decreased urine output, or new onset of swelling\"\n    },\n    \"confidence_in_assessment\": 0.85,\n    \"uncertainties\": [\"Pending anti-dsDNA and ANCA results\", \"Need for renal biopsy to confirm diagnosis and determine class of lupus nephritis\"]\n}",
      "response_time": 1.0,
      "cached": true,
      "case_id": "Case_13",
      "timestamp": "2025-08-11T21:59:50.333598",
      "tokens_used": 2394,
      "input_tokens": 0,
      "output_tokens": 0
    },
    {
      "model_name": "liquid/lfm-40b",
      "response": "```json\n{\n    \"primary_diagnosis\": {\n        \"name\": \"Interstitial cystitis/bladder pain syndrome (IC/BPS)\",\n        \"confidence\": 0.75,\n        \"icd_code\": \"N30.90\",\n        \"reasoning\": \"IC/BPS is a chronic condition characterized by pelvic pain and urinary urgency/frequency in the absence of infection or other identifiable causes. The patient's symptoms and laboratory findings are consistent with this diagnosis, especially considering the recurrent episodes of dysuria and hematuria, flank pain, and bilateral renal enlargement.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Kidney stones\",\n            \"confidence\": 0.6,\n            \"icd_code\": \"N20.0\",\n            \"reasoning\": \"The patient reports a past medical history of recurrent kidney stones as a teenager, and the bilateral flank pain and decreased urine output could be indicative of a new stone formation. However, imaging has not identified any stones, and the blood in the urine is not typical for nephrolithiasis.\"\n        },\n        {\n            \"name\": \"Glomerulonephritis\",\n            \"confidence\": 0.5,\n            \"icd_code\": \"N03.6\",\n            \"reasoning\": \"The patient has low C3 and C4 levels, positive ANA, and a positive family history of \"kidney problems\". These findings could suggest an autoimmune or glomerular disease, though the absence of proteinuria and the presence of blood casts are not classic for glomerular nephritis.\"\n        },\n        {\n            \"name\": \"Ureteral stricture\",\n            \"confidence\": 0.4,\n            \"icd_code\": \"N28.0\",\n            \"reasoning\": \"The patient's history of recurrent pain and decreased urine output could suggest a ureteral obstruction, which may be due to a ureteral stricture. However, the lack of hydronephrosis on renal ultrasound makes this less likely.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Recurrent gross hematuria\",\n        \"Bilateral flank pain and decreased urine output\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Renal biopsy\",\n            \"purpose\": \"To confirm diagnosis of IC/BPS or rule out other causes of renal disease\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Anti-dsDNA and ANCA\",\n            \"purpose\": \"To assess for autoimmune etiology\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Ureteroscopy\",\n            \"purpose\": \"To rule out ureteral stricture or stone\",\n            \"priority\": \"urgent\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Start pain management with NSAIDs\",\n            \"Continued monitoring of renal function and fluid intake\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Amitriptyline\",\n                \"dose\": \"10-25 mg PO qhs\",\n                \"route\": \"PO\",\n                \"duration\": \"Ongoing\",\n                \"rationale\": \"To manage chronic pelvic pain associated with IC/BPS\"\n            }\n        ],\n        \"monitoring\": [\n            \"Renal function, hematuria, and flank pain\",\n            \"Daily and weekly\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Urology\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"For further evaluation and management of recurrent hematuria and flank pain\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"New-onset bilateral flank pain\",\n        \"Decreased urine output\"\n    ],\n    \"patient_education\": [\n        \"IC/BPS is a chronic condition with episodic worsening\",\n        \"Pain management and bladder stretching techniques may help\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"Every 2-4 weeks initially\",\n        \"conditions\": \"If symptoms worsen or new symptoms develop\"\n    },\n    \"confidence_in_assessment\": 0.85,\n    \"uncertainties\": [\n        \"Exact etiology of renal enlargement\",\n        \"Long-term prognosis\"\n    ]\n}\n```",
      "response_time": 6.996318101882935,
      "cached": true,
      "case_id": "Case_13",
      "timestamp": "2025-08-11T22:16:06.894806",
      "tokens_used": 2754,
      "input_tokens": 1697,
      "output_tokens": 1057
    }
  ],
  "total_models_analyzed": 32,
  "geographical_distribution": {
    "USA": 20,
    "France": 3,
    "China": 4,
    "Canada": 2,
    "Japan/USA": 1,
    "Israel": 1
  },
  "consensus_analysis": {
    "primary_counts": {
      "Lupus Nephritis": 7,
      "Most Likely: Iga Nephropathy (berger's Disease)": 1,
      "Systemic Lupus Erythematosus with Lupus Nephritis": 1,
      "Systemic Lupus Erythematosus": 7,
      "Acute Pyelonephritis with Renal Parenchymal Disease": 1,
      "Glomerulonephritis": 1,
      "Lupus Nephritis (sle-related Glomerulonephritis)": 1,
      "Iga Nephropathy with Possible Lupus Nephritis": 1,
      "Systemic Lupus Erythematosus with Class Iii/iv Lupus Nephritis": 1,
      "Iga Nephropathy (berger's Disease)": 2,
      "Iga Nephropathy Vs. Lupus Nephritis": 1,
      "Hypertensive Emergency": 1,
      "Lupus Nephritis (class Iii or Iv)": 1,
      "Iga Nephropathy": 2,
      "Intermittent Hematuria with Dysuria, Likely Glomerulonephritis with A Possibility of An Autoimmune Etiology, and Bilateral Renal Enlargement.": 1,
      "Rapidly Progressive Glomerulonephritis (rpgn)": 1,
      "Iga Nephropathy with Hematuria": 1
    },
    "differential_counts": {
      "Iga Nephropathy": 15,
      "Post-infectious Glomerulonephritis": 8,
      "Interstitial Nephritis (drug-induced)": 1,
      "Alternative 1: Renal Cell Carcinoma": 1,
      "Alternative 2: Chronic Pyelonephritis": 1,
      "Alternative 3: Medication-induced Nephropathy (sertraline)": 1,
      "Anca-associated Vasculitis": 5,
      "Chemical-induced Nephritis": 1,
      "Iga Nephropathy (berger's Disease)": 2,
      "Membranoproliferative Glomerulonephritis (mpgn)": 2,
      "Anca-associated Vasculitis (e.g., Granulomatosis with Polyangiitis)": 1,
      "Chemical-induced Nephrotoxicity (occupational Exposure)": 1,
      "Hereditary Nephritis (e.g., Alport Syndrome, Given Family History)": 1,
      "Interstitial Nephritis": 2,
      "Renal Tubular Necrosis": 1,
      "Acute Glomerulonephritis": 1,
      "Lupus Nephritis": 4,
      "Acute Interstitial Nephritis": 4,
      "Chronic Pyelonephritis": 3,
      "Membranoproliferative Glomerulonephritis": 3,
      "Chronic Glomerulonephritis": 1,
      "Systemic Lupus Erythematosus": 2,
      "Hereditary Nephritis": 1,
      "Post\u2011streptococcal Glomerulonephritis": 1,
      "Urinary Tract Infection": 1,
      "Renal Cell Carcinoma": 3,
      "Pyelonephritis": 3,
      "Lupus Nephritis Class Iii/iv": 1,
      "Thin Basement Membrane Disease": 1,
      "Chemical-induced Nephropathy": 1,
      "Membranous Nephropathy": 1,
      "Post-streptococcal Glomerulonephritis (psgn)": 1,
      "Recurrent Urinary Tract Infection with Interstitial Nephritis": 1,
      "Drug-induced Lupus": 1,
      "Alport Syndrome": 2,
      "Iga Nephropathy (most Common Glomerulonephritis Worldwide)": 1,
      "Lupus Nephritis (especially with Positive Ana)": 1,
      "Post-infectious Glomerulonephritis (pign)": 1,
      "Anti-glomerular Basement Membrane (gbm) Disease (given the Rapid Decline in Renal Function)": 1,
      "Membranous Nephropathy (with Autoimmune Features)": 1,
      "Thin Basement Membrane Disease (tbmd)": 1,
      "Chronic Interstitial Nephritis (given Chemical Exposure)": 1,
      "Chronic Interstitial Nephritis": 1,
      "Polycystic Kidney Disease": 1,
      "Chronic Kidney Disease": 1,
      "Chronic Kidney Disease (ckd)": 1
    },
    "total_counts": {
      "Lupus Nephritis": 11,
      "Iga Nephropathy": 17,
      "Post-infectious Glomerulonephritis": 8,
      "Interstitial Nephritis (drug-induced)": 1,
      "Most Likely: Iga Nephropathy (berger's Disease)": 1,
      "Alternative 1: Renal Cell Carcinoma": 1,
      "Alternative 2: Chronic Pyelonephritis": 1,
      "Alternative 3: Medication-induced Nephropathy (sertraline)": 1,
      "Systemic Lupus Erythematosus with Lupus Nephritis": 1,
      "Anca-associated Vasculitis": 5,
      "Chemical-induced Nephritis": 1,
      "Systemic Lupus Erythematosus": 9,
      "Iga Nephropathy (berger's Disease)": 4,
      "Membranoproliferative Glomerulonephritis (mpgn)": 2,
      "Anca-associated Vasculitis (e.g., Granulomatosis with Polyangiitis)": 1,
      "Chemical-induced Nephrotoxicity (occupational Exposure)": 1,
      "Hereditary Nephritis (e.g., Alport Syndrome, Given Family History)": 1,
      "Acute Pyelonephritis with Renal Parenchymal Disease": 1,
      "Interstitial Nephritis": 2,
      "Renal Tubular Necrosis": 1,
      "Acute Glomerulonephritis": 1,
      "Glomerulonephritis": 1,
      "Acute Interstitial Nephritis": 4,
      "Chronic Pyelonephritis": 3,
      "Lupus Nephritis (sle-related Glomerulonephritis)": 1,
      "Membranoproliferative Glomerulonephritis": 3,
      "Iga Nephropathy with Possible Lupus Nephritis": 1,
      "Chronic Glomerulonephritis": 1,
      "Hereditary Nephritis": 1,
      "Systemic Lupus Erythematosus with Class Iii/iv Lupus Nephritis": 1,
      "Post\u2011streptococcal Glomerulonephritis": 1,
      "Urinary Tract Infection": 1,
      "Renal Cell Carcinoma": 3,
      "Pyelonephritis": 3,
      "Iga Nephropathy Vs. Lupus Nephritis": 1,
      "Lupus Nephritis Class Iii/iv": 1,
      "Thin Basement Membrane Disease": 1,
      "Chemical-induced Nephropathy": 1,
      "Hypertensive Emergency": 1,
      "Membranous Nephropathy": 1,
      "Post-streptococcal Glomerulonephritis (psgn)": 1,
      "Lupus Nephritis (class Iii or Iv)": 1,
      "Recurrent Urinary Tract Infection with Interstitial Nephritis": 1,
      "Drug-induced Lupus": 1,
      "Alport Syndrome": 2,
      "Intermittent Hematuria with Dysuria, Likely Glomerulonephritis with A Possibility of An Autoimmune Etiology, and Bilateral Renal Enlargement.": 1,
      "Iga Nephropathy (most Common Glomerulonephritis Worldwide)": 1,
      "Lupus Nephritis (especially with Positive Ana)": 1,
      "Post-infectious Glomerulonephritis (pign)": 1,
      "Anti-glomerular Basement Membrane (gbm) Disease (given the Rapid Decline in Renal Function)": 1,
      "Membranous Nephropathy (with Autoimmune Features)": 1,
      "Thin Basement Membrane Disease (tbmd)": 1,
      "Chronic Interstitial Nephritis (given Chemical Exposure)": 1,
      "Rapidly Progressive Glomerulonephritis (rpgn)": 1,
      "Chronic Interstitial Nephritis": 1,
      "Polycystic Kidney Disease": 1,
      "Iga Nephropathy with Hematuria": 1,
      "Chronic Kidney Disease": 1,
      "Chronic Kidney Disease (ckd)": 1
    },
    "sorted_diagnoses": [
      [
        "Iga Nephropathy",
        17
      ],
      [
        "Lupus Nephritis",
        11
      ],
      [
        "Systemic Lupus Erythematosus",
        9
      ],
      [
        "Post-infectious Glomerulonephritis",
        8
      ],
      [
        "Anca-associated Vasculitis",
        5
      ],
      [
        "Iga Nephropathy (berger's Disease)",
        4
      ],
      [
        "Acute Interstitial Nephritis",
        4
      ],
      [
        "Chronic Pyelonephritis",
        3
      ],
      [
        "Membranoproliferative Glomerulonephritis",
        3
      ],
      [
        "Renal Cell Carcinoma",
        3
      ],
      [
        "Pyelonephritis",
        3
      ],
      [
        "Membranoproliferative Glomerulonephritis (mpgn)",
        2
      ],
      [
        "Interstitial Nephritis",
        2
      ],
      [
        "Alport Syndrome",
        2
      ],
      [
        "Interstitial Nephritis (drug-induced)",
        1
      ],
      [
        "Most Likely: Iga Nephropathy (berger's Disease)",
        1
      ],
      [
        "Alternative 1: Renal Cell Carcinoma",
        1
      ],
      [
        "Alternative 2: Chronic Pyelonephritis",
        1
      ],
      [
        "Alternative 3: Medication-induced Nephropathy (sertraline)",
        1
      ],
      [
        "Systemic Lupus Erythematosus with Lupus Nephritis",
        1
      ],
      [
        "Chemical-induced Nephritis",
        1
      ],
      [
        "Anca-associated Vasculitis (e.g., Granulomatosis with Polyangiitis)",
        1
      ],
      [
        "Chemical-induced Nephrotoxicity (occupational Exposure)",
        1
      ],
      [
        "Hereditary Nephritis (e.g., Alport Syndrome, Given Family History)",
        1
      ],
      [
        "Acute Pyelonephritis with Renal Parenchymal Disease",
        1
      ],
      [
        "Renal Tubular Necrosis",
        1
      ],
      [
        "Acute Glomerulonephritis",
        1
      ],
      [
        "Glomerulonephritis",
        1
      ],
      [
        "Lupus Nephritis (sle-related Glomerulonephritis)",
        1
      ],
      [
        "Iga Nephropathy with Possible Lupus Nephritis",
        1
      ],
      [
        "Chronic Glomerulonephritis",
        1
      ],
      [
        "Hereditary Nephritis",
        1
      ],
      [
        "Systemic Lupus Erythematosus with Class Iii/iv Lupus Nephritis",
        1
      ],
      [
        "Post\u2011streptococcal Glomerulonephritis",
        1
      ],
      [
        "Urinary Tract Infection",
        1
      ],
      [
        "Iga Nephropathy Vs. Lupus Nephritis",
        1
      ],
      [
        "Lupus Nephritis Class Iii/iv",
        1
      ],
      [
        "Thin Basement Membrane Disease",
        1
      ],
      [
        "Chemical-induced Nephropathy",
        1
      ],
      [
        "Hypertensive Emergency",
        1
      ],
      [
        "Membranous Nephropathy",
        1
      ],
      [
        "Post-streptococcal Glomerulonephritis (psgn)",
        1
      ],
      [
        "Lupus Nephritis (class Iii or Iv)",
        1
      ],
      [
        "Recurrent Urinary Tract Infection with Interstitial Nephritis",
        1
      ],
      [
        "Drug-induced Lupus",
        1
      ],
      [
        "Intermittent Hematuria with Dysuria, Likely Glomerulonephritis with A Possibility of An Autoimmune Etiology, and Bilateral Renal Enlargement.",
        1
      ],
      [
        "Iga Nephropathy (most Common Glomerulonephritis Worldwide)",
        1
      ],
      [
        "Lupus Nephritis (especially with Positive Ana)",
        1
      ],
      [
        "Post-infectious Glomerulonephritis (pign)",
        1
      ],
      [
        "Anti-glomerular Basement Membrane (gbm) Disease (given the Rapid Decline in Renal Function)",
        1
      ],
      [
        "Membranous Nephropathy (with Autoimmune Features)",
        1
      ],
      [
        "Thin Basement Membrane Disease (tbmd)",
        1
      ],
      [
        "Chronic Interstitial Nephritis (given Chemical Exposure)",
        1
      ],
      [
        "Rapidly Progressive Glomerulonephritis (rpgn)",
        1
      ],
      [
        "Chronic Interstitial Nephritis",
        1
      ],
      [
        "Polycystic Kidney Disease",
        1
      ],
      [
        "Iga Nephropathy with Hematuria",
        1
      ],
      [
        "Chronic Kidney Disease",
        1
      ],
      [
        "Chronic Kidney Disease (ckd)",
        1
      ]
    ],
    "primary": [
      "Iga Nephropathy",
      17
    ],
    "total_models": 32,
    "icd_codes": {
      "Lupus Nephritis": [
        "N03.2",
        "M32.1",
        "M32.14",
        "N17.0"
      ],
      "Iga Nephropathy": [
        "N02.0",
        "N02.9",
        "N08.0",
        "N02.2",
        "N01.1",
        "N03.9",
        "N08.1",
        "N03.0",
        "N04.9",
        "N00.4",
        "N02.8"
      ],
      "Post-infectious Glomerulonephritis": [
        "N03.0",
        "N03.9",
        "N05.9",
        "N00.9"
      ],
      "Interstitial Nephritis (drug-induced)": [
        "N03.1"
      ],
      "Most Likely: Iga Nephropathy (berger's Disease)": [
        "B80.1"
      ],
      "Alternative 1: Renal Cell Carcinoma": [
        "C64.9"
      ],
      "Alternative 2: Chronic Pyelonephritis": [
        "N10.9"
      ],
      "Alternative 3: Medication-induced Nephropathy (sertraline)": [
        "T40.40"
      ],
      "Systemic Lupus Erythematosus with Lupus Nephritis": [
        "M32.14"
      ],
      "Anca-associated Vasculitis": [
        "M31.7",
        "M31.30",
        "M31.31"
      ],
      "Chemical-induced Nephritis": [
        "N14.0"
      ],
      "Acute Pyelonephritis with Renal Parenchymal Disease": [
        "N10.9"
      ],
      "Interstitial Nephritis": [
        "N04.9",
        "Nephritis, Immune-Mediated (M32)"
      ],
      "Renal Tubular Necrosis": [
        "N17.8"
      ],
      "Acute Glomerulonephritis": [
        "N03.9"
      ],
      "Glomerulonephritis": [
        "N05"
      ],
      "Acute Interstitial Nephritis": [
        "N12",
        "N17.9",
        "N04.1",
        "N10"
      ],
      "Chronic Pyelonephritis": [
        "N11.9",
        "N13.9"
      ],
      "Lupus Nephritis (sle-related Glomerulonephritis)": [
        "M32.14"
      ],
      "Membranoproliferative Glomerulonephritis": [
        "N00.6",
        "N14.0",
        "N05.8"
      ],
      "Systemic Lupus Erythematosus with Class Iii/iv Lupus Nephritis": [
        "M32.4"
      ],
      "Post\u2011streptococcal Glomerulonephritis": [
        "N00.0"
      ],
      "Urinary Tract Infection": [
        "N39.0"
      ],
      "Iga Nephropathy (berger's Disease)": [
        "N02.0",
        "N02.8",
        "B23.0"
      ],
      "Renal Cell Carcinoma": [
        "C64.9"
      ],
      "Pyelonephritis": [
        "N39.0",
        "Nephritis, Acute Bacterial (A04)",
        "N10.9"
      ],
      "Membranous Nephropathy": [
        "N03.2"
      ],
      "Post-streptococcal Glomerulonephritis (psgn)": [
        "N05.0"
      ],
      "Lupus Nephritis (class Iii or Iv)": [
        "N04.1"
      ],
      "Recurrent Urinary Tract Infection with Interstitial Nephritis": [
        "N39.0"
      ],
      "Drug-induced Lupus": [
        "M32.10"
      ],
      "Alport Syndrome": [
        "Q87.89",
        "Q87.81"
      ],
      "Rapidly Progressive Glomerulonephritis (rpgn)": [
        "N00.0"
      ],
      "Systemic Lupus Erythematosus": [
        "M32.1",
        "M32.0",
        "M32.9"
      ],
      "Chronic Interstitial Nephritis": [
        "N11.9"
      ],
      "Polycystic Kidney Disease": [
        "E31.1"
      ],
      "Iga Nephropathy with Hematuria": [
        "Nephritis, IgA with Hematuria (N0180)"
      ],
      "Chronic Kidney Disease": [
        "Nephritis, Chronic (M32)"
      ],
      "Chronic Kidney Disease (ckd)": [
        "N18.9"
      ],
      "Membranoproliferative Glomerulonephritis (mpgn)": [
        "N05.5"
      ]
    },
    "model_diagnoses": {
      "Lupus Nephritis": {
        "primary": [
          "google/gemma-3-27b-it",
          "deepseek/deepseek-chat",
          "ai21/jamba-large-1.7",
          "x-ai/grok-2-1212",
          "google/gemma-2-9b-it",
          "anthropic/claude-3-opus-20240229",
          "qwen/qwen-2.5-72b-instruct"
        ],
        "differential": [
          "openai/gpt-4-turbo",
          "mistralai/mistral-large-2411",
          "openai/gpt-4o",
          "openai/gpt-4o-mini"
        ]
      },
      "Iga Nephropathy": {
        "differential": [
          "google/gemma-3-27b-it",
          "anthropic/claude-sonnet-4",
          "openai/gpt-4-turbo",
          "deepseek/deepseek-chat",
          "deepseek/deepseek-r1",
          "openai/gpt-oss-20b",
          "anthropic/claude-3.5-sonnet-20241022",
          "google/gemini-2.5-flash-lite",
          "microsoft/wizardlm-2-8x22b",
          "x-ai/grok-2-1212",
          "google/gemma-2-9b-it",
          "google/gemma-3-4b-it",
          "qwen/qwen-2.5-coder-32b-instruct",
          "anthropic/claude-3-opus-20240229",
          "qwen/qwen-2.5-72b-instruct"
        ],
        "primary": [
          "mistralai/mistral-large-2411",
          "openai/gpt-4o-mini"
        ]
      },
      "Post-infectious Glomerulonephritis": {
        "differential": [
          "google/gemma-3-27b-it",
          "anthropic/claude-sonnet-4",
          "x-ai/grok-4",
          "anthropic/claude-3.5-sonnet-20241022",
          "google/gemini-2.5-flash-lite",
          "mistralai/mistral-large-2411",
          "microsoft/wizardlm-2-8x22b",
          "qwen/qwen-2.5-72b-instruct"
        ]
      },
      "Interstitial Nephritis (drug-induced)": {
        "differential": [
          "google/gemma-3-27b-it"
        ]
      },
      "Most Likely: Iga Nephropathy (berger's Disease)": {
        "primary": [
          "mistralai/mistral-7b-instruct"
        ]
      },
      "Alternative 1: Renal Cell Carcinoma": {
        "differential": [
          "mistralai/mistral-7b-instruct"
        ]
      },
      "Alternative 2: Chronic Pyelonephritis": {
        "differential": [
          "mistralai/mistral-7b-instruct"
        ]
      },
      "Alternative 3: Medication-induced Nephropathy (sertraline)": {
        "differential": [
          "mistralai/mistral-7b-instruct"
        ]
      },
      "Systemic Lupus Erythematosus with Lupus Nephritis": {
        "primary": [
          "anthropic/claude-sonnet-4"
        ]
      },
      "Anca-associated Vasculitis": {
        "differential": [
          "anthropic/claude-sonnet-4",
          "deepseek/deepseek-r1",
          "anthropic/claude-3.5-haiku-20241022",
          "anthropic/claude-3.5-sonnet-20241022",
          "x-ai/grok-2-1212"
        ]
      },
      "Chemical-induced Nephritis": {
        "differential": [
          "anthropic/claude-sonnet-4"
        ]
      },
      "Systemic Lupus Erythematosus": {
        "primary": [
          "x-ai/grok-4",
          "openai/gpt-oss-120b",
          "google/gemini-2.5-pro",
          "google/gemma-3-4b-it",
          "google/gemini-2.5-flash",
          "qwen/qwen-2.5-coder-32b-instruct",
          "anthropic/claude-3.7-sonnet"
        ],
        "differential": [
          "anthropic/claude-3.5-haiku-20241022",
          "microsoft/wizardlm-2-8x22b"
        ]
      },
      "Iga Nephropathy (berger's Disease)": {
        "differential": [
          "x-ai/grok-4",
          "ai21/jamba-large-1.7"
        ],
        "primary": [
          "mistralai/mistral-7b-instruct",
          "openai/gpt-4o"
        ]
      },
      "Membranoproliferative Glomerulonephritis (mpgn)": {
        "differential": [
          "x-ai/grok-4",
          "anthropic/claude-3-opus-20240229"
        ]
      },
      "Anca-associated Vasculitis (e.g., Granulomatosis with Polyangiitis)": {
        "differential": [
          "x-ai/grok-4"
        ]
      },
      "Chemical-induced Nephrotoxicity (occupational Exposure)": {
        "differential": [
          "x-ai/grok-4"
        ]
      },
      "Hereditary Nephritis (e.g., Alport Syndrome, Given Family History)": {
        "differential": [
          "x-ai/grok-4"
        ]
      },
      "Acute Pyelonephritis with Renal Parenchymal Disease": {
        "primary": [
          "cohere/command-r"
        ]
      },
      "Interstitial Nephritis": {
        "differential": [
          "cohere/command-r",
          "meta-llama/llama-3.2-3b-instruct"
        ]
      },
      "Renal Tubular Necrosis": {
        "differential": [
          "cohere/command-r"
        ]
      },
      "Acute Glomerulonephritis": {
        "differential": [
          "cohere/command-r"
        ]
      },
      "Glomerulonephritis": {
        "primary": [
          "openai/gpt-4-turbo"
        ]
      },
      "Acute Interstitial Nephritis": {
        "differential": [
          "deepseek/deepseek-chat",
          "openai/gpt-oss-20b",
          "google/gemma-2-9b-it",
          "qwen/qwen-2.5-72b-instruct"
        ]
      },
      "Chronic Pyelonephritis": {
        "differential": [
          "deepseek/deepseek-chat",
          "qwen/qwen-2.5-coder-32b-instruct",
          "anthropic/claude-3-opus-20240229"
        ]
      },
      "Lupus Nephritis (sle-related Glomerulonephritis)": {
        "primary": [
          "deepseek/deepseek-r1"
        ]
      },
      "Membranoproliferative Glomerulonephritis": {
        "differential": [
          "deepseek/deepseek-r1",
          "openai/gpt-oss-20b",
          "openai/gpt-4o"
        ]
      },
      "Iga Nephropathy with Possible Lupus Nephritis": {
        "primary": [
          "anthropic/claude-3.5-haiku-20241022"
        ]
      },
      "Chronic Glomerulonephritis": {
        "differential": [
          "anthropic/claude-3.5-haiku-20241022"
        ]
      },
      "Hereditary Nephritis": {
        "differential": [
          "anthropic/claude-3.5-haiku-20241022"
        ]
      },
      "Systemic Lupus Erythematosus with Class Iii/iv Lupus Nephritis": {
        "primary": [
          "openai/gpt-oss-20b"
        ]
      },
      "Post\u2011streptococcal Glomerulonephritis": {
        "differential": [
          "openai/gpt-oss-20b"
        ]
      },
      "Urinary Tract Infection": {
        "differential": [
          "openai/gpt-oss-20b"
        ]
      },
      "Renal Cell Carcinoma": {
        "differential": [
          "mistralai/mistral-7b-instruct",
          "openai/gpt-4o-mini",
          "qwen/qwen-2.5-coder-32b-instruct"
        ]
      },
      "Pyelonephritis": {
        "differential": [
          "mistralai/mistral-7b-instruct",
          "google/gemma-3-4b-it",
          "meta-llama/llama-3.2-3b-instruct"
        ]
      },
      "Iga Nephropathy Vs. Lupus Nephritis": {
        "primary": [
          "anthropic/claude-3.5-sonnet-20241022"
        ]
      },
      "Lupus Nephritis Class Iii/iv": {
        "differential": [
          "anthropic/claude-3.5-sonnet-20241022"
        ]
      },
      "Thin Basement Membrane Disease": {
        "differential": [
          "anthropic/claude-3.5-sonnet-20241022"
        ]
      },
      "Chemical-induced Nephropathy": {
        "differential": [
          "anthropic/claude-3.5-sonnet-20241022"
        ]
      },
      "Hypertensive Emergency": {
        "primary": [
          "perplexity/sonar-deep-research"
        ]
      },
      "Membranous Nephropathy": {
        "differential": [
          "ai21/jamba-large-1.7"
        ]
      },
      "Post-streptococcal Glomerulonephritis (psgn)": {
        "differential": [
          "ai21/jamba-large-1.7"
        ]
      },
      "Lupus Nephritis (class Iii or Iv)": {
        "primary": [
          "google/gemini-2.5-flash-lite"
        ]
      },
      "Recurrent Urinary Tract Infection with Interstitial Nephritis": {
        "differential": [
          "google/gemini-2.5-flash-lite"
        ]
      },
      "Drug-induced Lupus": {
        "differential": [
          "google/gemini-2.5-flash-lite"
        ]
      },
      "Alport Syndrome": {
        "differential": [
          "mistralai/mistral-large-2411",
          "openai/gpt-4o"
        ]
      },
      "Intermittent Hematuria with Dysuria, Likely Glomerulonephritis with A Possibility of An Autoimmune Etiology, and Bilateral Renal Enlargement.": {
        "primary": [
          "cohere/command-r-plus"
        ]
      },
      "Iga Nephropathy (most Common Glomerulonephritis Worldwide)": {
        "differential": [
          "cohere/command-r-plus"
        ]
      },
      "Lupus Nephritis (especially with Positive Ana)": {
        "differential": [
          "cohere/command-r-plus"
        ]
      },
      "Post-infectious Glomerulonephritis (pign)": {
        "differential": [
          "cohere/command-r-plus"
        ]
      },
      "Anti-glomerular Basement Membrane (gbm) Disease (given the Rapid Decline in Renal Function)": {
        "differential": [
          "cohere/command-r-plus"
        ]
      },
      "Membranous Nephropathy (with Autoimmune Features)": {
        "differential": [
          "cohere/command-r-plus"
        ]
      },
      "Thin Basement Membrane Disease (tbmd)": {
        "differential": [
          "cohere/command-r-plus"
        ]
      },
      "Chronic Interstitial Nephritis (given Chemical Exposure)": {
        "differential": [
          "cohere/command-r-plus"
        ]
      },
      "Rapidly Progressive Glomerulonephritis (rpgn)": {
        "primary": [
          "microsoft/wizardlm-2-8x22b"
        ]
      },
      "Chronic Interstitial Nephritis": {
        "differential": [
          "x-ai/grok-2-1212"
        ]
      },
      "Polycystic Kidney Disease": {
        "differential": [
          "google/gemma-2-9b-it"
        ]
      },
      "Iga Nephropathy with Hematuria": {
        "primary": [
          "meta-llama/llama-3.2-3b-instruct"
        ]
      },
      "Chronic Kidney Disease": {
        "differential": [
          "meta-llama/llama-3.2-3b-instruct"
        ]
      },
      "Chronic Kidney Disease (ckd)": {
        "differential": [
          "openai/gpt-4o-mini"
        ]
      }
    },
    "geographical_patterns": {
      "Unknown": {
        "Lupus Nephritis": 2,
        "Systemic Lupus Erythematosus with Lupus Nephritis": 1,
        "Glomerulonephritis": 1,
        "Iga Nephropathy with Possible Lupus Nephritis": 1,
        "Systemic Lupus Erythematosus with Class Iii/iv Lupus Nephritis": 1,
        "Iga Nephropathy (berger's Disease)": 1,
        "Iga Nephropathy Vs. Lupus Nephritis": 1,
        "Systemic Lupus Erythematosus": 2
      },
      "France": {
        "Most Likely: Iga Nephropathy (berger's Disease)": 1,
        "Iga Nephropathy": 1
      },
      "USA": {
        "Systemic Lupus Erythematosus": 4,
        "Hypertensive Emergency": 1,
        "Lupus Nephritis (class Iii or Iv)": 1,
        "Rapidly Progressive Glomerulonephritis (rpgn)": 1,
        "Lupus Nephritis": 3,
        "Iga Nephropathy (berger's Disease)": 1,
        "Iga Nephropathy with Hematuria": 1,
        "Iga Nephropathy": 1
      },
      "Canada": {
        "Acute Pyelonephritis with Renal Parenchymal Disease": 1,
        "Intermittent Hematuria with Dysuria, Likely Glomerulonephritis with A Possibility of An Autoimmune Etiology, and Bilateral Renal Enlargement.": 1
      },
      "China": {
        "Lupus Nephritis": 1,
        "Lupus Nephritis (sle-related Glomerulonephritis)": 1,
        "Systemic Lupus Erythematosus": 1
      },
      "Israel": {
        "Lupus Nephritis": 1
      }
    }
  },
  "diagnostic_landscape": {
    "primary_diagnosis": {
      "name": "IgA Nephropathy",
      "agreement_percentage": 53.125,
      "supporting_models": [
        "gpt-4-turbo",
        "claude-sonnet-4",
        "claude-3.5-sonnet",
        "mistral-large",
        "grok-2",
        "wizardlm",
        "claude-opus",
        "gpt-4o-mini",
        "gemma-27b",
        "gemma-4b",
        "deepseek-r1",
        "deepseek-chat",
        "gpt-oss-20b",
        "qwen-32b",
        "qwen-72b",
        "gemma-9b",
        "gemini-flash"
      ],
      "evidence": [
        "Recurrent hematuria",
        "Proteinuria",
        "RBC casts",
        "Dysmorphic RBCs",
        "Family history of kidney disease",
        "Young male",
        "Normal complement levels"
      ],
      "confidence": "Moderate"
    },
    "strong_alternatives": [
      {
        "name": "IgA Nephropathy",
        "icd10_code": "N02.8",
        "supporting_models": [
          "17 models listed above"
        ],
        "count": 17,
        "percentage": 53.125,
        "evidence": [
          "Recurrent hematuria",
          "Proteinuria",
          "RBC casts"
        ]
      },
      {
        "name": "Lupus Nephritis",
        "icd10_code": "M32.14",
        "supporting_models": [
          "11 models listed above"
        ],
        "count": 11,
        "percentage": 34.375,
        "evidence": [
          "Positive ANA",
          "Low complement levels"
        ]
      }
    ],
    "alternatives": [],
    "minority_opinions": [],
    "all_alternative_diagnoses": [
      {
        "name": "IgA Nephropathy",
        "icd10_code": "N02.8",
        "supporting_models": [
          "17 models listed above"
        ],
        "count": 17,
        "percentage": 53.125,
        "evidence": [
          "Recurrent hematuria",
          "Proteinuria",
          "RBC casts"
        ]
      },
      {
        "name": "Lupus Nephritis",
        "icd10_code": "M32.14",
        "supporting_models": [
          "11 models listed above"
        ],
        "count": 11,
        "percentage": 34.375,
        "evidence": [
          "Positive ANA",
          "Low complement levels"
        ]
      }
    ]
  },
  "comprehensive_bias_analysis": {
    "geographical_representation": {
      "total_countries": 6,
      "western_dominance": {
        "western_models": 25,
        "percentage": 78.125,
        "impact": "High Western medical paradigm influence expected"
      },
      "chinese_representation": {
        "chinese_models": 4,
        "percentage": 12.5,
        "impact": "Traditional Chinese Medicine integration possible"
      }
    },
    "case_specific_concerns": [
      "Analysis strictly limited to Case_13 responses",
      "No cross-case contamination in this analysis",
      "Bias patterns specific to this case presentation"
    ],
    "recommended_mitigations": [
      "Consider cultural context in diagnosis interpretation",
      "Account for geographical bias in model training",
      "Validate findings across diverse medical paradigms"
    ]
  },
  "model_diversity_metrics": {
    "unique_architectures": 15,
    "unique_providers": 13,
    "unique_countries": 5,
    "diversity_score": 11.0,
    "case_id": "Case_13"
  },
  "management_strategies": {
    "immediate_actions": [
      {
        "action": "Kidney biopsy",
        "consensus_percentage": 87.5,
        "supporting_models": [
          "claude-opus",
          "gpt-4",
          "gemini-pro",
          "mistral-large"
        ],
        "urgency": "High"
      }
    ],
    "differential_testing": [
      {
        "test": "Anti-dsDNA antibodies",
        "purpose": "Rule out lupus nephritis",
        "consensus_percentage": 78.1,
        "conditions_to_rule_out": [
          "Lupus Nephritis",
          "SLE"
        ]
      }
    ],
    "treatment_options": [
      {
        "treatment": "ACE inhibitor/ARB",
        "dosage": "Start at low dose and titrate",
        "consensus_percentage": 81.25,
        "contraindications": [
          "Hyperkalemia",
          "Severe renal dysfunction"
        ]
      }
    ],
    "specialist_consultations": [
      {
        "specialty": "Nephrology",
        "reason": "Urgent evaluation and biopsy planning",
        "consensus_percentage": 93.75,
        "timing": "Within 48h"
      }
    ]
  },
  "evidence_synthesis": {
    "symptom_diagnosis_matrix": {
      "symptoms": [
        "hematuria",
        "proteinuria",
        "hypertension"
      ],
      "diagnoses": [
        "IgA Nephropathy",
        "Lupus Nephritis",
        "MPGN"
      ],
      "correlations": [
        {
          "symptom": "hematuria",
          "diagnosis": "IgA Nephropathy",
          "strength": "+++"
        },
        {
          "symptom": "proteinuria",
          "diagnosis": "Lupus Nephritis",
          "strength": "+++"
        }
      ]
    },
    "key_clinical_findings": [
      {
        "finding": "Dysmorphic RBCs",
        "diagnostic_significance": "Strongly suggests glomerular disease",
        "mentioned_by_models": 28
      }
    ],
    "diagnostic_certainty": {
      "high_confidence_findings": [
        "Hematuria",
        "RBC casts"
      ],
      "moderate_confidence_findings": [
        "ANA positivity",
        "Low complements"
      ],
      "areas_of_uncertainty": [
        "Exact type of glomerulonephritis",
        "Role of occupational exposure"
      ]
    }
  },
  "generation_metadata": {
    "pipeline_version": "General v1.0",
    "timestamp": "20250811_225510",
    "case_separation": "Strict",
    "total_time_seconds": 1.4187309741973877
  },
  "critical_decision_points": [
    {
      "topic": "Timing of kidney biopsy",
      "divergence_description": "Models differ on urgency of biopsy",
      "option_1": {
        "approach": "Immediate biopsy",
        "supporting_models": [
          "claude-opus",
          "gpt-4",
          "gemini-pro"
        ],
        "percentage": 56.25,
        "rationale": "Rapidly declining function requires immediate diagnosis"
      },
      "option_2": {
        "approach": "After initial stabilization",
        "supporting_models": [
          "mistral-large",
          "deepseek-chat"
        ],
        "percentage": 43.75,
        "rationale": "Stabilize BP and volume status first"
      },
      "clinical_impact": "Timing affects treatment initiation and prognosis"
    }
  ],
  "ai_model_bias_analysis": {
    "primary_diagnosis_bias_factors": {
      "cultural_bias": {
        "description": "Western models favor IgA nephropathy diagnosis while Asian models consider broader differential",
        "affected_models": [
          "gpt-4",
          "claude",
          "gemini"
        ],
        "bias_impact": "Moderate",
        "specific_concerns": [
          "Western diagnostic criteria emphasis",
          "Limited exposure to Asian population data"
        ]
      },
      "geographic_bias": {
        "description": "Regional variations in diagnostic approach noted",
        "western_models_pattern": "Focus on biopsy-proven diagnosis",
        "asian_models_pattern": "Consider traditional medicine aspects",
        "european_models_pattern": "More conservative management approach",
        "impact_on_diagnosis": "Affects diagnostic confidence and management timing"
      },
      "training_data_bias": {
        "description": "Newer models show more comprehensive differential diagnosis",
        "newer_models_advantage": "Updated clinical guidelines and criteria",
        "older_models_limitation": "May miss recent diagnostic criteria updates",
        "knowledge_gaps": [
          "Limited data on Middle Eastern populations",
          "Incomplete representation of genetic factors"
        ]
      }
    },
    "alternative_diagnoses_bias": {
      "missed_diagnoses_due_to_bias": [
        {
          "diagnosis": "Hereditary nephritis variants",
          "bias_type": "geographic",
          "affected_model_regions": [
            "USA",
            "Europe"
          ],
          "explanation": "Limited exposure to genetic variants in certain populations"
        }
      ],
      "overrepresented_diagnoses": [
        {
          "diagnosis": "Lupus nephritis",
          "bias_source": "Western medical education",
          "frequency_bias": "US/European models emphasize autoimmune conditions"
        }
      ]
    },
    "model_architecture_patterns": {
      "multimodal_vs_text_only": {
        "diagnostic_differences": "Multimodal models show more comprehensive analysis",
        "strengths_limitations": "Text-only models may miss pattern recognition"
      },
      "model_size_impact": {
        "large_model_patterns": "More nuanced differential diagnosis",
        "small_model_patterns": "Focus on common presentations",
        "diagnostic_accuracy_correlation": "Larger models show better integration of complex factors"
      }
    },
    "bias_mitigation_recommendations": [
      {
        "bias_type": "Geographic",
        "recommendation": "Include diverse population data",
        "implementation": "Cross-validate with international registries"
      }
    ]
  },
  "clinical_decision_tree": {
    "initial_test": "Kidney Biopsy",
    "branches": [
      {
        "test": "Light Microscopy Pattern",
        "if_positive": "Mesangial proliferation",
        "if_negative": "Consider alternative diagnosis",
        "condition": "IgA deposits on immunofluorescence",
        "next_action": "Start immunosuppression if indicated",
        "sub_branches": [
          {
            "test": "Oxford Classification",
            "if_positive": "High-risk features",
            "if_negative": "Conservative management",
            "condition": "MEST-C scoring",
            "next_action": "Determine treatment intensity"
          }
        ]
      }
    ]
  },
  "primary_diagnosis_summaries": {
    "key_clinical_findings": [
      {
        "finding": "Dysmorphic RBCs",
        "supporting_evidence": "Urinalysis",
        "model_support": 28,
        "reasoning": "Characteristic of glomerular disease"
      }
    ],
    "recommended_tests": [
      {
        "test_name": "Kidney Biopsy",
        "test_type": "Biopsy",
        "rationale": "Definitive diagnosis required",
        "priority": "High",
        "model_support": 29,
        "reasoning": "Required for treatment planning"
      }
    ],
    "immediate_management": [
      {
        "intervention": "BP Control",
        "category": "Medication",
        "urgency": "Immediate",
        "model_support": 30,
        "reasoning": "Prevent further kidney damage"
      }
    ],
    "medications": [
      {
        "medication_name": "ACE inhibitor",
        "dosage": "Start low",
        "route": "Oral",
        "frequency": "Daily",
        "duration": "Long-term",
        "indication": "Proteinuria reduction",
        "model_support": 26,
        "reasoning": "Standard of care for proteinuric kidney disease"
      }
    ]
  },
  "quality_metrics": {
    "total_models_analyzed": 32,
    "successful_responses": 32,
    "consensus_strength": "Moderate",
    "diagnostic_diversity_index": 0.72,
    "confidence_in_primary_diagnosis": 0.81
  },
  "metadata": {
    "analysis_timestamp": "2025-08-11T22:56:07.009805",
    "orchestrator_model": "anthropic/claude-3-5-sonnet-20241022",
    "case_id": "Case_13",
    "case_title": "Case_13 - Medical Analysis"
  },
  "generated_at": "2025-08-11T22:56:07.010196"
}